Guidelines

Non-neurogenic Female LUTS

5. REFERENCES

1.Abrams, P., et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn, 2002. 21: 167.

https://pubmed.ncbi.nlm.nih.gov/11857671/

2.Milsom, I., et al. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology, 2012. 80: 90.

https://pubmed.ncbi.nlm.nih.gov/22748867/

3.Felde, G., et al. Anxiety and depression associated with urinary incontinence. A 10-year follow-up study from the Norwegian HUNT study (EPINCONT). Neurourol Urodyn, 2017. 36: 322.

https://pubmed.ncbi.nlm.nih.gov/26584597/

4.Eapen, R.S., et al. Review of the epidemiology of overactive bladder. Res Rep Urol, 2016. 8: 71.

https://pubmed.ncbi.nlm.nih.gov/27350947/

5.Coyne, K.S., et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int, 2009. 104: 352.

https://pubmed.ncbi.nlm.nih.gov/19281467/

6.Coyne, K.S., et al. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int, 2009. 103 Suppl 3: 4.

https://pubmed.ncbi.nlm.nih.gov/19302497/

7.Irwin, D.E., et al. The economic impact of overactive bladder syndrome in six Western countries. BJU Int, 2009. 103: 202.

https://pubmed.ncbi.nlm.nih.gov/19278532/

8.Abrams, P., et al. 5th International Consultation on Incontinence, Paris, February 2012.

https://www.ics.org/Publications/ICI_5/INCONTINENCE.pdf

9.Blok, B., et al. EAU Guidelines on Neuro-urology. Edn. presented at the 37th EAU Annual Congress Amsterdam. 2022, EAU Guidelines Office, Arnhem, The Netherlands.

https://pubmed.ncbi.nlm.nih.gov/19403235/

10.Radmayr, C., et al. EAU Guidelines on Paediatric Urology. Edn. presented at the 37th EAU Annual Congress Amsterdam. 2022, EAU Guidelines Office, Arnhem, The Netherlands.

https://uroweb.org/guideline/paediatric-urology/

11.Fawzy F., et al. What are the benefits and potential harms of the surgical and non-surgical treatment options for the management of women with overactive bladder syndrome? Prospero, 2021.

https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=192207

12.Guyatt, G.H., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008. 336: 924.

https://pubmed.ncbi.nlm.nih.gov/18436948/

13.Guyatt, G.H., et al. What is “quality of evidence” and why is it important to clinicians? BMJ, 2008. 336: 995.

https://pubmed.ncbi.nlm.nih.gov/18456631/

14.Phillips B, et al. Oxford Centre for Evidence-based Medicine Levels of Evidence. Updated by Jeremy Howick March 2009. 1998.

https://www.cebm.net/2009/06/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/

15.Guyatt, G.H., et al. Going from evidence to recommendations. BMJ, 2008. 336: 1049.

https://pubmed.ncbi.nlm.nih.gov/18467413/

16.D’Ancona, C., et al. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn, 2019. 38: 433.

https://pubmed.ncbi.nlm.nih.gov/30681183/

17.Bonkat, G., et al. EAU Guidelines on Urological Infections. Edn. presented at the 37th EAU Annual Congress Amsterdam. 2022, EAU Guidelines Office, Arnhem, The Netherlands.

https://uroweb.org/guideline/urological-infections/

18.Engeler, D., et al. EAU Guidelines on Chronic Pelvic Pain. Edn. presented at the 37th EAU Annual Congress Amsterdam. 2022, EAU Guidelines Office, Arnhem, The Netherlands.

https://uroweb.org/guideline/chronic-pelvic-pain/

19.Martin, L., et al. Comparison of Methods to Identify Stress Urinary Incontinence in Women With Pelvic Organ Prolapse. Female Pelvic Med Reconstr Surg, 2021. 27: e127.

https://pubmed.ncbi.nlm.nih.gov/33369965/

20.U.S. Department of Health and Human Services, F.a.D.A. Guidance for Industry - Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009. [access data March 2022].

https://www.fda.gov/media/77832/download

21.Farrell, S.A., et al. Women’s ability to assess their urinary incontinence type using the QUID as an educational tool. Int Urogynecol J, 2013. 24: 759.

https://pubmed.ncbi.nlm.nih.gov/22940842/

22.Hess, R., et al. Long-term efficacy and safety of questionnaire-based initiation of urgency urinary incontinence treatment. Am J Obstet Gynecol, 2013. 209: 244 e1.

https://pubmed.ncbi.nlm.nih.gov/23659987/

23.ICIQ Development Group. International Consultation on Incontinence Questionnaire Female Lower Urinary Tract Symptoms Modules (ICIQ-FLUTS) ICIQ Project, 2014.

https://iciq.net/iciq-fluts

24.Chapple, C., et al. Validation of the Overactive Bladder-Bladder Assessment Tool (OAB-BAT): A Potential Alternative to the Standard Bladder Diary for Monitoring OAB Outcomes. Eur Urol Focus, 2021. 7: 1176.

https://pubmed.ncbi.nlm.nih.gov/33451958/

25.Malde, S., et al. Case-finding tools for the diagnosis of OAB in women: A narrative review. Neurourol Urodyn, 2020. 39: 13.

https://pubmed.ncbi.nlm.nih.gov/31578764/

26.Chan, S.S., et al. Responsiveness of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire in women undergoing treatment for pelvic floor disorders. Int Urogynecol J, 2013.
|24: 213.

https://pubmed.ncbi.nlm.nih.gov/22669425/

27.Kim, J., et al. 1576 Is there a relationship between incontinence impact questionnaire 7 score after surgery for stress urinary incontiennce and patient-perceived satisfaction and improvement? J Urol, 2013. 189: e647.

https://www.auajournals.org/doi/full/10.1016/j.juro.2013.02.3126

28.Wuytack, F., et al. A systematic review of utility-based and disease-specific quality of life measurement instruments for women with urinary incontinence. Neurourol Urodyn, 2021. 40: 1275.

https://pubmed.ncbi.nlm.nih.gov/34082483/

29.Rosier, P.F.W.M. et al. Committee 6. Urodynamic testing, In: Incontinence, P. Abrams, L. Cardozo, A. Wagg, A. Wein, Eds. 2017, CI-ICS. International Continence Society: Bristol UK.

https://www.ics.org/publications/ici_6/Incontinence_6th_Edition_2017_eBook_v2.pdf

30.Shy, M., et al. Objective Evaluation of Overactive Bladder: Which Surveys Should I Use? Curr Bladder Dysfunct Rep, 2013. 8: 45.

https://pubmed.ncbi.nlm.nih.gov/23439804/

31.Haylen, B.T., et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery. Neurourol Urodyn, 2011. 30: 2.

https://pubmed.ncbi.nlm.nih.gov/21181958/

32.Brown, J.S., et al. Measurement characteristics of a voiding diary for use by men and women with overactive bladder. Urology, 2003. 61: 802.

https://pubmed.ncbi.nlm.nih.gov/12670569/

33.Nygaard, I., et al. Reproducibility of the seven-day voiding diary in women with stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct, 2000. 11: 15.

https://pubmed.ncbi.nlm.nih.gov/10738929/

34.Bright, E., et al. Developing and validating the International Consultation on Incontinence Questionnaire bladder diary. Eur Urol, 2014. 66: 294.

https://pubmed.ncbi.nlm.nih.gov/24647230/

35.Jimenez-Cidre, M.A., et al. The 3-day bladder diary is a feasible, reliable and valid tool to evaluate the lower urinary tract symptoms in women. Neurourol Urodyn, 2015. 34: 128.

https://pubmed.ncbi.nlm.nih.gov/24264859/

36.Ertberg, P., et al. A comparison of three methods to evaluate maximum bladder capacity: cystometry, uroflowmetry and a 24-h voiding diary in women with urinary incontinence. Acta Obstet Gynecol Scand, 2003. 82: 374.

https://pubmed.ncbi.nlm.nih.gov/12716323/

37.Fitzgerald, M.P., et al. Variability of 24-hour voiding diary variables among asymptomatic women.
J Urol, 2003. 169: 207.

https://pubmed.ncbi.nlm.nih.gov/12478137/

38.Burgio, K.L., et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA, 1998. 280: 1995.

https://pubmed.ncbi.nlm.nih.gov/9863850/

39.Fayyad, A.M., et al. Urine production and bladder diary measurements in women with type 2 diabetes mellitus and their relation to lower urinary tract symptoms and voiding dysfunction. Neurourol Urodyn, 2010. 29: 354.

https://pubmed.ncbi.nlm.nih.gov/19760759/

40.Homma, Y., et al. Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score. Urology, 2011. 77: 60.

https://pubmed.ncbi.nlm.nih.gov/20951412/

41.Stav, K., et al. Women overestimate daytime urinary frequency: the importance of the bladder diary. J Urol, 2009. 181: 2176.

https://pubmed.ncbi.nlm.nih.gov/19296975/

42.van Brummen, H.J., et al. The association between overactive bladder symptoms and objective parameters from bladder diary and filling cystometry. Neurourol Urodyn, 2004. 23: 38.

https://pubmed.ncbi.nlm.nih.gov/14694455/

43.Yap, T.L., et al. A systematic review of the reliability of frequency-volume charts in urological research and its implications for the optimum chart duration. BJU Int, 2007. 99: 9.

https://pubmed.ncbi.nlm.nih.gov/16956355/

44.Bright, E., et al. Urinary diaries: evidence for the development and validation of diary content, format, and duration. Neurourol Urodyn, 2011. 30: 348.

https://pubmed.ncbi.nlm.nih.gov/21284023/

45.Buchsbaum, G.M., et al. Utility of urine reagent strip in screening women with incontinence for urinary tract infection. Int Urogynecol J Pelvic Floor Dysfunct, 2004. 15: 391.

https://pubmed.ncbi.nlm.nih.gov/15278254/

46.Arinzon, Z., et al. Clinical presentation of urinary tract infection (UTI) differs with aging in women. Arch Gerontol Geriatr, 2012. 55: 145.

https://pubmed.ncbi.nlm.nih.gov/21963175/

47.Moore, E.E., et al. Urinary incontinence and urinary tract infection: temporal relationships in postmenopausal women. Obstet Gynecol, 2008. 111: 317.

https://pubmed.ncbi.nlm.nih.gov/18238968/

48.Ouslander, J.G., et al. Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents? Ann Intern Med, 1995. 122: 749.

https://pubmed.ncbi.nlm.nih.gov/7717597/

49.Griffiths, D.J., et al. Variability of post-void residual urine volume in the elderly. Urol Res, 1996. 24: 23.

https://pubmed.ncbi.nlm.nih.gov/8966837/

50.Marks, L.S., et al. Three-dimensional ultrasound device for rapid determination of bladder volume. Urology, 1997. 50: 341.

https://pubmed.ncbi.nlm.nih.gov/9301695/

51.Nygaard, I.E. Postvoid residual volume cannot be accurately estimated by bimanual examination. Int Urogynecol J Pelvic Floor Dysfunct, 1996. 7: 74.

https://pubmed.ncbi.nlm.nih.gov/8798090/

52.Ouslander, J.G., et al. Use of a portable ultrasound device to measure post-void residual volume among incontinent nursing home residents. J Am Geriatr Soc, 1994. 42: 1189.

https://pubmed.ncbi.nlm.nih.gov/7963206/

53.Stoller, M.L., et al. The accuracy of a catheterized residual urine. J Urol, 1989. 141: 15.

https://pubmed.ncbi.nlm.nih.gov/2908944/

54.Gehrich, A., et al. Establishing a mean postvoid residual volume in asymptomatic perimenopausal and postmenopausal women. Obstet Gynecol, 2007. 110: 827.

https://pubmed.ncbi.nlm.nih.gov/17906016/

55.Robinson, D., et al. Defining female voiding dysfunction: ICI-RS 2011. Neurourol Urodyn, 2012. 31: 313.

https://pubmed.ncbi.nlm.nih.gov/22415792/

56.Haylen, B.T., et al. Immediate postvoid residual volumes in women with symptoms of pelvic floor dysfunction. Obstet Gynecol, 2008. 111: 1305.

https://pubmed.ncbi.nlm.nih.gov/18515513/

57.Lukacz, E.S., et al. Elevated postvoid residual in women with pelvic floor disorders: prevalence and associated risk factors. Int Urogynecol J Pelvic Floor Dysfunct, 2007. 18: 397.

https://pubmed.ncbi.nlm.nih.gov/16804634/

58.Milleman, M., et al. Post-void residual urine volume in women with overactive bladder symptoms.
J Urol, 2004. 172: 1911.

https://pubmed.ncbi.nlm.nih.gov/15540753/

59.Tseng, L.H., et al. Postvoid residual urine in women with stress incontinence. Neurourol Urodyn, 2008. 27: 48.

https://pubmed.ncbi.nlm.nih.gov/17563112/

60.Siroky, M.B., et al. The flow rate nomogram: I. Development. J Urol, 1979. 122: 665.

https://pubmed.ncbi.nlm.nih.gov/159366/

61.Haylen, B.T., et al. Maximum and average urine flow rates in normal male and female populations--the Liverpool nomograms. Br J Urol, 1989. 64: 30.

https://pubmed.ncbi.nlm.nih.gov/2765766/

62.Rosier, P., et al. International Continence Society Good Urodynamic Practices and Terms 2016: Urodynamics, uroflowmetry, cystometry, and pressure-flow study. Neurourol Urodyn, 2017. 36: 1243.

https://pubmed.ncbi.nlm.nih.gov/27917521/

63.Abrams, P., et al. United Kingdom Continence Society: Minimum standards for urodynamic studies, 2018. Neurourol Urodyn, 2019. 38: 838.

https://pubmed.ncbi.nlm.nih.gov/30648750/

64.Dorflinger, A., et al. Urethral pressure profile: is it affected by position? Neurourol Urodyn, 2002.
21: 553.

https://pubmed.ncbi.nlm.nih.gov/12382246/

65.Wang, A.C., et al. A comparison of urethral pressure profilometry using microtip and double-lumen perfusion catheters in women with genuine stress incontinence. BJOG, 2002. 109: 322.

https://pubmed.ncbi.nlm.nih.gov/11950188/

66.Zehnder, P., et al. Air charged and microtip catheters cannot be used interchangeably for urethral pressure measurement: a prospective, single-blind, randomized trial. J Urol, 2008. 180: 1013.

https://pubmed.ncbi.nlm.nih.gov/18639301/

67.NICE Guidance – Urinary incontinence and pelvic organ prolapse in women: management. BJU International, 2019. 123: 777.

https://pubmed.ncbi.nlm.nih.gov/31008559/

68.van Leijsen, S.A., et al. The correlation between clinical and urodynamic diagnosis in classifying the type of urinary incontinence in women. A systematic review of the literature. Neurourol Urodyn, 2011. 30: 495.

https://pubmed.ncbi.nlm.nih.gov/21298721/

69.Schick, E., et al. Predictive value of maximum urethral closure pressure, urethral hypermobility and urethral incompetence in the diagnosis of clinically significant female genuine stress incontinence.
J Urol, 2004. 171: 1871.

https://pubmed.ncbi.nlm.nih.gov/15076296/

70.Albo, M.E., et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med, 2007. 356: 2143.

https://pubmed.ncbi.nlm.nih.gov/17517855/

71.Klarskov, N. Urethral pressure reflectometry. A method for simultaneous measurements of pressure and cross-sectional area in the female urethra. Dan Med J, 2012. 59: B4412.

https://pubmed.ncbi.nlm.nih.gov/22381095/

72.Dokmeci, F., et al. Comparison of ambulatory versus conventional urodynamics in females with urinary incontinence. Neurourol Urodyn, 2010. 29: 518.

https://pubmed.ncbi.nlm.nih.gov/19731314/

73.Radley, S.C., et al. Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity. J Urol, 2001. 166: 2253.

https://pubmed.ncbi.nlm.nih.gov/11696746/

74.Pang, K.H., et al. Diagnostic Tests for Female Bladder Outlet Obstruction: A Systematic Review from the European Association of Urology Non-neurogenic Female LUTS Guidelines Panel. Eur Urol Focus, 2021. S2405: 00231.

https://pubmed.ncbi.nlm.nih.gov/34538750/

75.Rademakers, K., et al. Recommendations for future development of contractility and obstruction nomograms for women. ICI-RS 2014. Neurourol Urodyn, 2016. 35: 307.

https://pubmed.ncbi.nlm.nih.gov/26872573/

76.Osman, N.I., et al. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol, 2014. 65: 389.

https://pubmed.ncbi.nlm.nih.gov/24184024/

77.Nitti, V.W., et al. Diagnosing bladder outlet obstruction in women. J Urol, 1999. 161: 1535.

https://pubmed.ncbi.nlm.nih.gov/10210391/

78.Clement, K.D., et al. Urodynamic studies for management of urinary incontinence in children and adults. Cochrane Database Syst Rev, 2013. 2013: CD003195.

https://pubmed.ncbi.nlm.nih.gov/24166676/

79.Rachaneni, S., et al. Does preoperative urodynamics improve outcomes for women undergoing surgery for stress urinary incontinence? A systematic review and meta-analysis. BJOG, 2015. 122: 8.

https://pubmed.ncbi.nlm.nih.gov/25041381/

80.Nager, C.W., et al. A randomized trial of urodynamic testing before stress-incontinence surgery.
N Engl J Med, 2012. 366: 1987.

https://pubmed.ncbi.nlm.nih.gov/22551104/

81.Serati, M., et al. Urodynamics useless before surgery for female stress urinary incontinence: Are you sure? Results from a multicenter single nation database. Neurourol Urodyn, 2016. 35: 809.

https://pubmed.ncbi.nlm.nih.gov/26061435/

82.Gravas, S., et al. EAU Guidelines on the management of Non-neurogenic Male LUTS. Edn. presented at the 37th EAU Annual Congress Amsterdam. 2022, EAU Guidelines Office, Arnhem, The Netherlands.

https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/

83.Nager, C.W., et al. Baseline urodynamic predictors of treatment failure 1 year after mid urethral sling surgery. J Urol, 2011. 186: 597.

https://pubmed.ncbi.nlm.nih.gov/21683412/

84.Lin, F.C., et al. The Role of Urodynamic Testing Prior to Third-Line OAB Therapy. Curr Bladder Dysf Rep, 2020. 15: 159.

https://www.researchgate.net/publication/341978617

85.Nitti, V.W., et al. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. BJU Int, 2010. 105: 1268.

https://pubmed.ncbi.nlm.nih.gov/19889062/

86.Dawson, T., et al. Factors predictive of post-TVT voiding dysfunction. Int Urogynecol J Pelvic Floor Dysfunct, 2007. 18: 1297.

https://pubmed.ncbi.nlm.nih.gov/17347790/

87.Hong, B., et al. Factors predictive of urinary retention after a tension-free vaginal tape procedure for female stress urinary incontinence. J Urol, 2003. 170: 852.

https://pubmed.ncbi.nlm.nih.gov/12913715/

88.Miller, E.A., et al. Preoperative urodynamic evaluation may predict voiding dysfunction in women undergoing pubovaginal sling. J Urol, 2003. 169: 2234.

https://pubmed.ncbi.nlm.nih.gov/12771757/

89.Groen, J., et al. Bladder contraction strength parameters poorly predict the necessity of long-term catheterization after a pubovaginal rectus fascial sling procedure. J Urol, 2004. 172: 1006.

https://pubmed.ncbi.nlm.nih.gov/15311024/

90.Abdel-Fattah, M., et al. Pelvicol pubovaginal sling versus tension-free vaginal tape for treatment of urodynamic stress incontinence: a prospective randomized three-year follow-up study. Eur Urol, 2004. 46: 629.

https://pubmed.ncbi.nlm.nih.gov/15474274/

91.Lemack, G.E., et al. Normal preoperative urodynamic testing does not predict voiding dysfunction after Burch colposuspension versus pubovaginal sling. J Urol, 2008. 180: 2076.

https://pubmed.ncbi.nlm.nih.gov/18804239/

92.Al Afraa, T., et al. Normal lower urinary tract assessment in women: I. Uroflowmetry and post-void residual, pad tests, and bladder diaries. Int Urogynecol J, 2012. 23: 681.

https://pubmed.ncbi.nlm.nih.gov/21935667/

93.Krhut, J., et al. Pad weight testing in the evaluation of urinary incontinence. Neurourol Urodyn, 2014. 33: 507.

https://pubmed.ncbi.nlm.nih.gov/23797972/

94.Painter, V., et al. Does patient activity level affect 24-hr pad test results in stress-incontinent women? Neurourol Urodyn, 2012. 31: 143.

https://pubmed.ncbi.nlm.nih.gov/21780173/

95.Rimstad, L., et al. Pad stress tests with increasing load for the diagnosis of stress urinary incontinence. Neurourol Urodyn, 2014. 33: 1135.

https://pubmed.ncbi.nlm.nih.gov/23913797/

96.Costantini, E., et al. Sensitivity and specificity of one-hour pad test as a predictive value for female urinary incontinence. Urol Int, 2008. 81: 153.

https://pubmed.ncbi.nlm.nih.gov/18758212/

97.Richter, H.E., et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstet Gynecol, 2011. 117: 913.

https://pubmed.ncbi.nlm.nih.gov/21422865/

98.Ward, K.L., et al. A prospective multicenter randomized trial of tension-free vaginal tape and colposuspension for primary urodynamic stress incontinence: two-year follow-up. Am J Obstet Gynecol, 2004. 190: 324.

https://pubmed.ncbi.nlm.nih.gov/14981369/

99.Lose, G., et al. Pad-weighing test performed with standardized bladder volume. Urology, 1988. 32: 78.

https://pubmed.ncbi.nlm.nih.gov/3388665/

100.Khullar, V., et al. , Committee 7 Imaging, neurophysiological testing and other tests, In: Incontinence P. Abrams, L. Cardozo, A. Wagg, A. Wein, Eds, 2017, ICI-ICS. International Continence Society: Bristol, UK.

https://www.ics.org/publications/ici_6/Incontinence_6th_Edition_2017_eBook_v2.pdf

101.Deng, S., et al. ROC analysis and significance of transperineal ultrasound in the diagnosis of stress urinary incontinence. J Med Imaging Health Info, 2020. 10: 113.

https://www.ingentaconnect.com/content/asp/jmihi/2020/00000010/00000001/art00019;jsessionid=2kc469smid7os.x-ic-live-02

102.Keshavarz, E., et al. Prediction of Stress Urinary Incontinence Using the Retrovesical (beta) Angle in Transperineal Ultrasound. J Ultrasound Med, 2021. 40: 1485.

https://pubmed.ncbi.nlm.nih.gov/33035377/

103.Illiano, E., et al. Translabial ultrasound: a non-invasive technique for assessing “technical errors” after TOT failure. Int Urogynecol J, 2021.

https://pubmed.ncbi.nlm.nih.gov/34191103/

104.Panayi, D.C., et al. Transvaginal ultrasound measurement of bladder wall thickness: a more reliable approach than transperineal and transabdominal approaches. BJU Int, 2010. 106: 1519.

https://pubmed.ncbi.nlm.nih.gov/20438565/

105.Antunes-Lopes, T., et al. Biomarkers in lower urinary tract symptoms/overactive bladder: a critical overview. Curr Opin Urol, 2014. 24: 352.

https://pubmed.ncbi.nlm.nih.gov/24841379/

106.Lekskulchai, O., et al. Is detrusor hypertrophy in women associated with voiding dysfunction? Aust N Z J Obstet Gynaecol, 2009. 49: 653.

https://pubmed.ncbi.nlm.nih.gov/20070717/

107.Woodfield, C.A., et al. Imaging pelvic floor disorders: trend toward comprehensive MRI. AJR Am
J Roentgenol, 2010. 194: 1640.

https://pubmed.ncbi.nlm.nih.gov/20489108/

108.Lockhart, M.E., et al. Reproducibility of dynamic MR imaging pelvic measurements: a multi-institutional study. Radiology, 2008. 249: 534.

https://pubmed.ncbi.nlm.nih.gov/18796659/

109.Shek, K.L., et al. The urethral motion profile before and after suburethral sling placement. J Urol, 2010. 183: 1450.

https://pubmed.ncbi.nlm.nih.gov/20171657/

110.Chantarasorn, V., et al. Sonographic appearance of transobturator slings: implications for function and dysfunction. Int Urogynecol J, 2011. 22: 493.

https://pubmed.ncbi.nlm.nih.gov/20967418/

111.Mossa, A.H., et al. Urinary metabolomics predict the severity of overactive bladder syndrome in an aging female population. Int Urogynecol J, 2020. 31: 1023.

https://pubmed.ncbi.nlm.nih.gov/31813035/

112.Govender, Y., et al. The Current Evidence on the Association Between the Urinary Microbiome and Urinary Incontinence in Women. Front Cell Infect Microbiol, 2019. 1: 9.

https://pubmed.ncbi.nlm.nih.gov/31119104/

113.Haylen, B.T., et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn, 2010. 29: 4.

https://pubmed.ncbi.nlm.nih.gov/19941278/

114.Irwin, D.E., et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol, 2006. 50: 1306.

https://pubmed.ncbi.nlm.nih.gov/17049716/

115.Tsiapakidou, S., et al. The use of urinary biomarkers in the diagnosis of overactive bladder in female patients. A systematic review and meta-analysis. Int Urogynecol J, 2021. 32: 3143/.

https://pubmed.ncbi.nlm.nih.gov/34363496/

116.Geng, V., et al. Catheterisation Indwelling catheters in adults – Urethral and Suprapubic - Evidence-based Guidelines for Best Practice in Urological Health Care. 2012 Edn. European Association of Urology Nurses (EAUN), Arnhem, the Netherlands.

http://nurses.uroweb.org/guideline/catheterisation-indwelling-catheters-in-adults-urethral-and-suprapubic/

117.Brazzelli, M., et al. Absorbent products for containing urinary and/or fecal incontinence in adults.
J Wound Ostomy Continence Nurs, 2002. 29: 45.

https://pubmed.ncbi.nlm.nih.gov/11810074/

118.Fader, M., et al. A multi-centre evaluation of absorbent products for men with light urinary incontinence. Neurourol Urodyn, 2006. 25: 689.

https://pubmed.ncbi.nlm.nih.gov/17009303/

119.Fader, M., et al. Absorbent products for urinary/faecal incontinence: a comparative evaluation of key product designs. Health Technol Assess, 2008. 12: iii.

https://pubmed.ncbi.nlm.nih.gov/18547500/

120.Jahn, P., et al. Types of indwelling urinary catheters for long-term bladder drainage in adults. Cochrane Database Syst Rev, 2012. 10: CD004997.

https://pubmed.ncbi.nlm.nih.gov/23076911/

121.Hunter, K.F., et al. Long-term bladder drainage: Suprapubic catheter versus other methods: a scoping review. Neurourol Urodyn, 2013. 32: 944.

https://pubmed.ncbi.nlm.nih.gov/23192860/

122.Tauzin-Fin, P., et al. Sublingual oxybutynin reduces postoperative pain related to indwelling bladder catheter after radical retropubic prostatectomy. Br J Anaesth, 2007. 99: 572.

https://pubmed.ncbi.nlm.nih.gov/17681969/

123.Agarwal, A., et al. The efficacy of tolterodine for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study. Anesth Analg, 2005. 101: 1065.

https://pubmed.ncbi.nlm.nih.gov/16192522/

124.Chung, J.M., et al. Evaluation of the Efficacy of Solifenacin for Preventing Catheter-Related Bladder Discomfort After Transurethral Resection of Bladder Tumors in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective, Randomized, Multicenter Study. Clin Genitourin Cancer, 2017. 15: 157.

https://pubmed.ncbi.nlm.nih.gov/27346074/

125.Tijani, K.H., et al. Role of tolterodine in the management of postoperative catheter-related bladder discomfort: Findings in a Nigerian teaching hospital. Niger J Clin Pract, 2017. 20: 484.

https://pubmed.ncbi.nlm.nih.gov/28406132/

126.Young, M.J., et al. Another Therapeutic Role for Intravesical Botulinum Toxin: Patients with Long-stay Catheters and Refractory Bladder Pain and Catheter Bypass Leakage. Eur Urol Focus, 2020. 6: 339.

https://pubmed.ncbi.nlm.nih.gov/30392867/

127.Prieto, J., et al. Intermittent catheterisation for long-term bladder management. Cochrane Database Syst Rev, 2014: CD006008.

https://pubmed.ncbi.nlm.nih.gov/25208303/

128.Tradewell, M., et al. Systematic review and practice policy statements on urinary tract infection prevention in adults with spina bifida. Transl Androl Urol, 2018. 7: S205.

https://pubmed.ncbi.nlm.nih.gov/29928619/

129.Woodbury, M.G., et al. Intermittent catheterization practices following spinal cord injury: a national survey. Can J Urol, 2008. 15: 4065.

https://pubmed.ncbi.nlm.nih.gov/18570710/

130.Cottenden A, et al. Management using continence products. In: Incontinence, C.L. Abrams P, Wagg A, Wein A, Editor. 2017, ICS ICUD.

https://www.ics.org/publications/ici_6/Incontinence_6th_Edition_2017_eBook_v2.pdf

131.Prieto, J., et al. Catheter designs, techniques and strategies for intermittent catheterisation: What is the evidence for preventing symptomatic UTI and other complications? A Cochrane systematic review. Eur Urol Suppl, 2014. 13: e762.

https://www.researchgate.net/publication/273616997_762

132.Hakansson, M.A. Reuse versus single-use catheters for intermittent catheterization: what is safe and preferred? Review of current status. Spinal Cord, 2014. 52: 511.

https://pubmed.ncbi.nlm.nih.gov/24861702/

133.Hagen, S., et al. Washout policies in long-term indwelling urinary catheterisation in adults. Cochrane Database Syst Rev, 2010: CD004012.

https://pubmed.ncbi.nlm.nih.gov/20238325/

134.Niel-Weise, B.S., et al. Urinary catheter policies for long-term bladder drainage. Cochrane Database Syst Rev, 2012: CD004201.

https://pubmed.ncbi.nlm.nih.gov/22895939/

135.Fisher, H., et al. Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial. Lancet Infect Dis. 2018. 18: 957.

https://pubmed.ncbi.nlm.nih.gov/30037647/

136.Arya, L.A., et al. Dietary caffeine intake and the risk for detrusor instability: a case-control study. Obstet Gynecol, 2000. 96: 85.

https://pubmed.ncbi.nlm.nih.gov/10862848/

137.Bryant, C.M., et al. Caffeine reduction education to improve urinary symptoms. Br J Nurs, 2002.
11: 560.

https://pubmed.ncbi.nlm.nih.gov/11979209/

138.Le Berre, M., et al. What do we really know about the role of caffeine on urinary tract symptoms? A scoping review on caffeine consumption and lower urinary tract symptoms in adults. Neurourol Urodyn, 2020. 39: 1217.

https://pubmed.ncbi.nlm.nih.gov/32270903/

139.Swithinbank, L., et al. The effect of fluid intake on urinary symptoms in women. J Urol, 2005.
174: 187.

https://pubmed.ncbi.nlm.nih.gov/15947624/

140.Dowd, T.T., et al. Fluid intake and urinary incontinence in older community-dwelling women.
J Community Health Nurs, 1996. 13: 179.

https://pubmed.ncbi.nlm.nih.gov/8916607/

141.Hashim, H., et al. How should patients with an overactive bladder manipulate their fluid intake? BJU Int, 2008. 102: 62.

https://pubmed.ncbi.nlm.nih.gov/18284414/

142.Zimmern, P., et al. Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women. BJU Int, 2010. 105: 1680.

https://pubmed.ncbi.nlm.nih.gov/19912207/

143.Hunskaar, S. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol Urodyn, 2008. 27: 749.

https://pubmed.ncbi.nlm.nih.gov/18951445/

144.Subak, L.L., et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med, 2009. 360: 481.

https://pubmed.ncbi.nlm.nih.gov/19179316/

145.Chen, C.C., et al. Obesity is associated with increased prevalence and severity of pelvic floor disorders in women considering bariatric surgery. Surg Obes Relat Dis, 2009. 5: 411.

https://pubmed.ncbi.nlm.nih.gov/19136310/

146.Hannestad, Y.S., et al. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG, 2003. 110: 247.

https://pubmed.ncbi.nlm.nih.gov/12628262/

147.Danforth, K.N., et al. Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol, 2006. 194: 339.

https://pubmed.ncbi.nlm.nih.gov/16458626/

148.Imamura, M., et al. Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess, 2010. 14: 1.

https://pubmed.ncbi.nlm.nih.gov/20738930/

149.Reisch, B., et al. Cognitive components of behavioral therapy for overactive bladder: a systematic review. Int Urogynecol J, 2021. 32: 2619.

https://pubmed.ncbi.nlm.nih.gov/33609161/

150.Eustice, S., et al. Prompted voiding for the management of urinary incontinence in adults. Cochrane Database Syst Rev, 2000: CD002113.

https://pubmed.ncbi.nlm.nih.gov/10796861/

151.Ostaszkiewicz, J., et al. Habit retraining for the management of urinary incontinence in adults. Cochrane Database Syst Rev, 2004. 2010: CD002801.

https://pubmed.ncbi.nlm.nih.gov/15106179/

152.Shamliyan, T., et al. Nonsurgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Apr. Report No.: 11-EHC074-EF.

https://pubmed.ncbi.nlm.nih.gov/22624162/

153.Rai, B.P., et al. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults. Cochrane Database Syst Rev, 2012. 12: CD003193.

https://pubmed.ncbi.nlm.nih.gov/23235594/

154.Shafik, A., et al. Overactive bladder inhibition in response to pelvic floor muscle exercises. World
J Urol, 2003. 20: 374.

https://pubmed.ncbi.nlm.nih.gov/12682771/

155.Huang, Z., et al. Efficacy of telemedicine for urinary incontinence in women: a systematic review and meta-analysis of randomized controlled trials. Int Urogynecol J, 2020. 31: 1507.

https://pubmed.ncbi.nlm.nih.gov/32476050 /

156.Stewart, F., et al. Electrical stimulation with non-implanted electrodes for overactive bladder in adults. Cochrane Database Syst Rev, 2016. 12: CD010098.

https://pubmed.ncbi.nlm.nih.gov/27935011/

157.Zhao, Y., et al. Acupuncture for adults with overactive bladder: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore), 2018. 97: e9838.

https://pubmed.ncbi.nlm.nih.gov/29465566/

158.Hargreaves, E., et al. Acupuncture for treating overactive bladder in adults. Cochrane Database Syst Rev, 2020. CD013519.

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013519/full

159.Finazzi-Agro, E., et al. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial.
J Urol, 2010. 184: 2001.

https://pubmed.ncbi.nlm.nih.gov/20850833/

160.Peters, K.M., et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol, 2010. 183: 1438.

https://pubmed.ncbi.nlm.nih.gov/20171677/

161.Wang, M., et al. Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis. Int Urogynecol J, 2020. 31: 2457.

https://pubmed.ncbi.nlm.nih.gov/32681345/

162.Peters, K.M., et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol, 2009. 182: 1055.

https://pubmed.ncbi.nlm.nih.gov/19616802/

163.Peters, K.M., et al. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol, 2013. 189: 2194.

https://pubmed.ncbi.nlm.nih.gov/23219541/

164.Schreiner, L., et al. Randomized trial of transcutaneous tibial nerve stimulation to treat urge urinary incontinence in older women. Int Urogynecol J, 2010. 21: 1065.

https://pubmed.ncbi.nlm.nih.gov/20458465/

165.Booth, J., et al. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review. Neurourol Urodyn, 2018. 37: 528.

https://pubmed.ncbi.nlm.nih.gov/28731583/

166.Sonmez, R., et al. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial. Ann Phys Rehabil Med, 2021. 65: 101486.

https://pubmed.ncbi.nlm.nih.gov/33429090/

167.Chapple, C., et al. The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol, 2005. 48: 5.

https://pubmed.ncbi.nlm.nih.gov/15885877/

168.Chapple, C.R., et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol, 2008. 54: 543.

https://pubmed.ncbi.nlm.nih.gov/18599186/

169.McDonagh, M.S., et al. Drug Class Review: Agents for Overactive Bladder: Final Report Update 4. 2009: Portland (OR).

https://pubmed.ncbi.nlm.nih.gov/21089246/

170.Shamliyan, T.A., et al. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med, 2008. 148: 459.

https://pubmed.ncbi.nlm.nih.gov/18268288/

171.Buser, N., et al. Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses. Eur Urol, 2012. 62: 1040.

https://pubmed.ncbi.nlm.nih.gov/22999811/

172.Reynolds, W.S., et al. Comparative Effectiveness of Anticholinergic Therapy for Overactive Bladder in Women: A Systematic Review and Meta-analysis. Obstet Gynecol, 2015. 125: 1423.

https://pubmed.ncbi.nlm.nih.gov/26000514/

173.Herbison, P., et al. Which anticholinergic is best for people with overactive bladders? A network meta-analysis. Neurourol Urodyn, 2019. 38: 525.

https://pubmed.ncbi.nlm.nih.gov/30575999/

174.Chapple, C., et al. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial. BJU Int, 2014. 114: 418.

https://pubmed.ncbi.nlm.nih.gov/24552358/

175.Kaplan, S.A., et al. Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER. Int J Clin Pract, 2014. 68: 1065.

https://pubmed.ncbi.nlm.nih.gov/24898471/

176.Goldfischer, E.R., et al. Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled study. Neurourol Urodyn, 2015. 34: 37.

https://pubmed.ncbi.nlm.nih.gov/24133005/

177.Nazir, J., et al. Comparative efficacy and tolerability of solifenacin 51398042195mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta-analysis. Neurourol Urodyn, 2018. 37: 986.

https://pubmed.ncbi.nlm.nih.gov/29140559/

178.Novara, G., et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol, 2008. 54: 740.

https://pubmed.ncbi.nlm.nih.gov/18632201/

179.Chapple, C., et al. Clinical efficacy, safety, and tolerability of once-daily fesoterodine in subjects with overactive bladder. Eur Urol, 2007. 52: 1204.

https://pubmed.ncbi.nlm.nih.gov/17651893/

180.Herschorn, S., et al. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial. BJU Int, 2010. 105: 58.

https://pubmed.ncbi.nlm.nih.gov/20132103/

181.DuBeau, C.E., et al. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials. Neurourol Urodyn, 2012. 31: 1258.

https://pubmed.ncbi.nlm.nih.gov/22907761/

182.Hartmann, K.E., et al. Treatment of overactive bladder in women. Evid Rep Technol Assess (Full Rep), 2009: 1.

https://pubmed.ncbi.nlm.nih.gov/19947666/

183.Goode, P.S., et al. Incontinence in older women. JAMA, 2010. 303: 2172.

https://pubmed.ncbi.nlm.nih.gov/20516418/

184.Gormley, E.A., et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol, 2012. 188: 2455.

https://pubmed.ncbi.nlm.nih.gov/23098785/

185.Mattiasson, A., et al. Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study. BJU Int, 2010.
105: 1126.

https://pubmed.ncbi.nlm.nih.gov/19818077/

186.Ayeleke, R.O., et al. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women. Cochrane Database Syst Rev,
2015: CD010551.

https://pubmed.ncbi.nlm.nih.gov/26526663/

187.Manriquez, V., et al. Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial. Eur J Obstet Gynecol Reprod Biol, 2016. 196: 6.

https://pubmed.ncbi.nlm.nih.gov/26645117/

188.Franzen, K., et al. Electrical stimulation compared with tolterodine for treatment of urge/urge incontinence amongst women--a randomized controlled trial. Int Urogynecol J, 2010. 21: 1517.

https://pubmed.ncbi.nlm.nih.gov/20585755/

189.Mostafaei, H., et al. Placebo Response in Patients with Oral Therapy for Overactive Bladder: A Systematic Review and Meta-analysis. Eur Urol Focus, 2021.

https://pubmed.ncbi.nlm.nih.gov/33674256/

190.Mostafaei, H., et al. Nocebo Response in the Pharmacological Management of Overactive Bladder: A Systematic Review and Meta-analysis. Eur Urol Focus, 2020. 7: 1143.

https://pubmed.ncbi.nlm.nih.gov/33153953/

191.Kosilov, K.V., et al. Randomized controlled trial of cyclic and continuous therapy with trospium and solifenacin combination for severe overactive bladder in elderly patients with regard to patient compliance. Ther Adv Urol, 2014. 6: 215.

https://pubmed.ncbi.nlm.nih.gov/25435915/

192.Nambiar, A.K., et al. EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence. Eur Urol, 2018. 73: 596.

https://pubmed.ncbi.nlm.nih.gov/29398262/

193.Sand, P.K., et al. Long-term safety, tolerability and efficacy of fesoterodine in subjects with overactive bladder symptoms stratified by age: pooled analysis of two open-label extension studies. Drugs Aging, 2012. 29: 119.

https://pubmed.ncbi.nlm.nih.gov/22276958/

194.Scarpero, H., et al. Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms. Curr Med Res Opin, 2011. 27: 921.

https://pubmed.ncbi.nlm.nih.gov/21355814/

195.D’Souza, A.O., et al. Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan. J Manag Care Pharm, 2008. 14: 291.

https://pubmed.ncbi.nlm.nih.gov/18439051/

196.Sears, C.L., et al. Overactive bladder medication adherence when medication is free to patients.
J Urol, 2010. 183: 1077.

https://pubmed.ncbi.nlm.nih.gov/20092838/

197.Shaya, F.T., et al. Persistence with overactive bladder pharmacotherapy in a Medicaid population. Am J Manag Care, 2005. 11: S121.

https://pubmed.ncbi.nlm.nih.gov/16161385/

198.Yeaw, J., et al. Comparing adherence and persistence across 6 chronic medication classes.
J Manag Care Pharm, 2009. 15: 728.

https://pubmed.ncbi.nlm.nih.gov/19954264/

199.Yu, Y.F., et al. Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program. Value Health, 2005. 8: 495.

https://pubmed.ncbi.nlm.nih.gov/16091027/

200.Kalder, M., et al. Discontinuation of treatment using anticholinergic medications in patients with urinary incontinence. Obstet Gynecol, 2014. 124: 794.

https://pubmed.ncbi.nlm.nih.gov/25198276/

201.Chapple, C.R., et al. Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn, 2014. 33: 17.

https://pubmed.ncbi.nlm.nih.gov/24127366/

202.Cui, Y., et al. The efficacy and safety of mirabegron in treating OAB: a systematic review and meta-analysis of phase III trials. Int Urol Nephrol, 2014. 46: 275.

https://pubmed.ncbi.nlm.nih.gov/23896942/

203.Herschorn, S., et al. A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the beta(3) adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder. Urology, 2013. 82: 313.

https://pubmed.ncbi.nlm.nih.gov/23769122/

204.Yamaguchi, O., et al. Phase III, randomised, double-blind, placebo-controlled study of the beta3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder. BJU Int, 2014. 113: 951.

https://pubmed.ncbi.nlm.nih.gov/24471907/

205.Wu, T., et al. The role of mirabegron in overactive bladder: a systematic review and meta-analysis. Urol Int, 2014. 93: 326.

https://pubmed.ncbi.nlm.nih.gov/25115445/

206.Maman, K., et al. Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison. Eur Urol, 2014. 65: 755.

https://pubmed.ncbi.nlm.nih.gov/24275310/

207.Athanasiou, S., et al. Mirabegron in female patients with overactive bladder syndrome: What’s new? A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol, 2020. 251: 73.

https://pubmed.ncbi.nlm.nih.gov/32480182/

208.Chapple, C.R., et al. Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a beta(3)-adrenoceptor agonist, in overactive bladder. Eur Urol, 2013. 63: 296.

https://pubmed.ncbi.nlm.nih.gov/23195283/

209.Shi, H., et al. The efficacy and safety of Vibegron in treating overactive bladder: A systematic review and pooled analysis of randomized controlled trials. Neurourol Urodyn, 2020. 39: 1255.

https://pubmed.ncbi.nlm.nih.gov/32421908/

210.Su, S., et al. Systematic review and meta-analysis of the efficacy and safety of vibegron vs antimuscarinic monotherapy for overactive bladder. Medicine (Baltimore), 2021. 100: e23171.

https://pubmed.ncbi.nlm.nih.gov/33592817/

211.Castro-Diaz, D., et al. The effect of mirabegron on patient-related outcomes in patients with overactive bladder: the results of post hoc correlation and responder analyses using pooled data from three randomized Phase III trials. Qual Life Res, 2015. 24: 1719.

https://pubmed.ncbi.nlm.nih.gov/25688038/

212.Chapple, C., et al. Efficacy of the beta3-adrenoceptor agonist mirabegron for the treatment of overactive bladder by severity of incontinence at baseline: a post hoc analysis of pooled data from three randomised phase 3 trials. Eur Urol, 2015. 67: 11.

https://pubmed.ncbi.nlm.nih.gov/25092537/

213.Malik, M., et al. Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study. Clin Pharmacol Ther, 2012. 92: 696.

https://pubmed.ncbi.nlm.nih.gov/23149929/

214.Martin, N., et al. Randomised, double-blind, placebo-controlled study to assess the ocular safety of mirabegron in normotensive IOP research subjects. Eur Urol Suppl, 2014. 13: e686.

https://pillbuys.com/research/Bicalutamide/2.pdf

215.Kelleher, C., et al. A post-HOC analysis of pooled data from 3 randomised phase 3 trials ofmirabegronin patients with overactive bladder (OAB): Correlations between objective and subjective outcome measures. Int Urogynecol J Pelvic Floor Dysfunct, 2013. 24: S119. [No abstract available].

216.Wagg, A., et al. Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada. Can Urol Assoc J, 2015. 9: 343.

https://pubmed.ncbi.nlm.nih.gov/26644809/

217.MacDiarmid, S., et al. Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy. J Urol, 2016. 196: 809.

https://pubmed.ncbi.nlm.nih.gov/27063854/

218.Tannenbaum, C., et al. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging, 2012. 29: 639.

https://pubmed.ncbi.nlm.nih.gov/22812538/

219.Gray, S.L., et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med, 2015. 175: 401.

https://pubmed.ncbi.nlm.nih.gov/25621434/

220.Risacher, S.L., et al. Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults. JAMA Neurol, 2016. 73: 721.

https://pubmed.ncbi.nlm.nih.gov/27088965/

221.Kessler, T.M., et al. Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach. PLoS One, 2011. 6: e16718.

https://pubmed.ncbi.nlm.nih.gov/21373193/

222.Paquette, A., et al. Systematic review and meta-analysis: do clinical trials testing antimuscarinic agents for overactive bladder adequately measure central nervous system adverse events? J Am Geriatr Soc, 2011. 59: 1332.

https://pubmed.ncbi.nlm.nih.gov/21718264/

223.Kay, G., et al. Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. Eur Urol, 2006. 50: 317.

https://pubmed.ncbi.nlm.nih.gov/16687205/

224.Isik, A.T., et al. Trospium and cognition in patients with late onset Alzheimer disease. J Nutr Health Aging, 2009. 13: 672.

https://pubmed.ncbi.nlm.nih.gov/19657549/

225.Lackner, T.E., et al. Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence. J Am Geriatr Soc, 2008. 56: 862.

https://pubmed.ncbi.nlm.nih.gov/18410326/

226.Wagg, A., et al. Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study. Eur Urol, 2013. 64: 74.

https://pubmed.ncbi.nlm.nih.gov/23332882/

227.Sink, K.M., et al. Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes. J Am Geriatr Soc, 2008. 56: 847.

https://pubmed.ncbi.nlm.nih.gov/18384584/

228.Wagg, A., et al. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis. Am J Geriatr Pharmacother, 2006. 4: 14.

https://pubmed.ncbi.nlm.nih.gov/16730617/

229.Wesnes, K.A., et al. Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg. Expert Opin Drug Saf, 2009. 8: 615.

https://pubmed.ncbi.nlm.nih.gov/19747069/

230.Zinner, N., et al. Impact of solifenacin on quality of life, medical care use, work productivity, and health utility in the elderly: an exploratory subgroup analysis. Am J Geriatr Pharmacother, 2009.
7: 373.

https://pubmed.ncbi.nlm.nih.gov/20129258/

231.Herschorn, S., et al. Tolerability of solifenacin and oxybutynin immediate release in older (> 65 years) and younger (</= 65 years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind study. Curr Med Res Opin, 2011. 27: 375.

https://pubmed.ncbi.nlm.nih.gov/21175373/

232.Drutz, H.P., et al. Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct, 1999. 10: 283.

https://pubmed.ncbi.nlm.nih.gov/10543335/

233.Michel, M.C., et al. Does gender or age affect the efficacy and safety of tolterodine? J Urol, 2002. 168: 1027.

https://pubmed.ncbi.nlm.nih.gov/12187215/

234.Millard, R., et al. Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity. J Urol, 1999. 161: 1551.

https://pubmed.ncbi.nlm.nih.gov/10210394/

235.Zinner, N.R., et al. Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients. J Am Geriatr Soc, 2002. 50: 799.

https://pubmed.ncbi.nlm.nih.gov/12028164/

236.Jumadilova, Z., et al. Retrospective evaluation of outcomes in patients with overactive bladder receiving tolterodine versus oxybutynin. Am J Health Syst Pharm, 2006. 63: 2357.

https://pubmed.ncbi.nlm.nih.gov/17106009/

237.Chapple, C., et al. Darifenacin treatment of patients >or= 65 years with overactive bladder: results of a randomized, controlled, 12-week trial. Curr Med Res Opin, 2007. 23: 2347.

https://pubmed.ncbi.nlm.nih.gov/17706004/

238.Lipton, R.B., et al. Assessment of cognitive function of the elderly population: effects of darifenacin. J Urol, 2005. 173: 493.

https://pubmed.ncbi.nlm.nih.gov/15643227/

239.Pietzko, A., et al. Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol, 1994. 47: 337.

https://pubmed.ncbi.nlm.nih.gov/7875185/

240.Todorova, A., et al. Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol, 2001. 41: 636.

https://pubmed.ncbi.nlm.nih.gov/11402632/

241.Staskin, D.R., et al. Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials. Int J Clin Pract, 2009. 63: 1715.

https://pubmed.ncbi.nlm.nih.gov/19930332/

242.Sand, P.K., et al. Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged >/= 75 years) with overactive bladder syndrome. BJU Int, 2011. 107: 612.

https://pubmed.ncbi.nlm.nih.gov/20707790/

243.Kraus, S.R., et al. Efficacy and tolerability of fesoterodine in older and younger subjects with overactive bladder. Urology, 2010. 76: 1350.

https://pubmed.ncbi.nlm.nih.gov/20974482/

244.Dubeau, C.E., et al. Effect of fesoterodine in vulnerable elderly subjects with urgency incontinence: a double-blind, placebo controlled trial. J Urol, 2014. 191: 395.

https://pubmed.ncbi.nlm.nih.gov/23973522/

245.Wagg, A., et al. Review of the efficacy and safety of fesoterodine for treating overactive bladder and urgency urinary incontinence in elderly patients. Drugs Aging, 2015. 32: 103.

https://pubmed.ncbi.nlm.nih.gov/25673122/

246.Ancelin, M.L., et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ, 2006. 332: 455.

https://pubmed.ncbi.nlm.nih.gov/16452102/

247.Wagg, A., et al. Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder. Int J Clin Pract, 2010. 64: 1279.

https://pubmed.ncbi.nlm.nih.gov/20529135/

248.Wagg, A., et al. Long-term safety, tolerability and efficacy of flexible-dose fesoterodine in elderly patients with overactive bladder: open-label extension of the SOFIA trial. Neurourol Urodyn, 2014. 33: 106.

https://pubmed.ncbi.nlm.nih.gov/23460503/

249.Boustani, M., et al. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health, 2008. 4: 311.

https://www.futuremedicine.com/doi/abs/10.2217/1745509X.4.3.311

250.Cai, X., et al. Long-term anticholinergic use and the aging brain. Alzheimers Dement, 2013. 9: 377.

https://pubmed.ncbi.nlm.nih.gov/23183138/

251.Campbell, N., et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging, 2009. 4: 225.

https://pubmed.ncbi.nlm.nih.gov/19554093/

252.Carriere, I., et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med, 2009. 169: 1317.

https://pubmed.ncbi.nlm.nih.gov/19636034/

253.Fox, C., et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc, 2011. 59: 1477.

https://pubmed.ncbi.nlm.nih.gov/21707557/

254.Rogers, R.G., et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction. Neurourol Urodyn, 2018. 37: 1220.

https://pubmed.ncbi.nlm.nih.gov/29441607/

255.Biehl, C., et al. A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause. Menopause, 2019. 26: 431.

https://pubmed.ncbi.nlm.nih.gov/30363010/

256.Cody, J.D., et al. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev, 2012. 10: CD001405.

https://pubmed.ncbi.nlm.nih.gov/23076892/

257.Lyytinen, H., et al. Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol, 2006. 108: 1354.

https://pubmed.ncbi.nlm.nih.gov/17138766/

258.Yumru, A.E., et al. The use of local 17beta-oestradiol treatment for improving vaginal symptoms associated with post-menopausal oestrogen deficiency. J Int Med Res, 2009. 37: 198.

https://pubmed.ncbi.nlm.nih.gov/19215691/

259.Mangera, A., et al. Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA). Eur Urol, 2011. 60: 784.

https://pubmed.ncbi.nlm.nih.gov/21782318/

260.Chapple, C., et al. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. Eur Urol, 2013. 64: 249.

https://pubmed.ncbi.nlm.nih.gov/23608668/

261.Veeratterapillay, R., et al. Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type1398042195A injections for detrusor overactivity. Int J Urol, 2014. 21: 175.

https://pubmed.ncbi.nlm.nih.gov/23819724/

262.Mohee, A., et al. Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB). BJU Int, 2013. 111: 106.

https://pubmed.ncbi.nlm.nih.gov/22672569/

263.Nitti, V.W., et al. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol, 2013. 189: 2186.

https://pubmed.ncbi.nlm.nih.gov/23246476/

264.Duthie, J.B., et al. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev, 2011: CD005493.

https://pubmed.ncbi.nlm.nih.gov/22161392/

265.White, W.M., et al. Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population. J Urol, 2008. 180: 2522.

https://pubmed.ncbi.nlm.nih.gov/18930481/

266.Nitti, V.W., et al. Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. J Urol, 2016. 196: 791.

https://pubmed.ncbi.nlm.nih.gov/27038769/

267.Visco, A.G., et al. Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence.
N Engl J Med, 2012. 367: 1803.

https://pubmed.ncbi.nlm.nih.gov/23036134/

268.Drake, M.J., et al. Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis. BJU Int, 2017. 120: 611.

https://pubmed.ncbi.nlm.nih.gov/28670786/

269.Rovner, E., et al. Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. Neurourol Urodyn, 2011. 30: 556.

https://pubmed.ncbi.nlm.nih.gov/21351127/

270.Jairam, R., et al. Predictive Factors in Sacral Neuromodulation: A Systematic Review. Urol Int, 2021. 1: 21.

https://pubmed.ncbi.nlm.nih.gov/34058731/

271.Herbison, G.P., et al. Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults. Cochrane Database Syst Rev, 2009: CD004202.

https://pubmed.ncbi.nlm.nih.gov/19370596/

272.Weil, E.H., et al. Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized clinical trial. Eur Urol, 2000. 37: 161.

https://pubmed.ncbi.nlm.nih.gov/10705194/

273.Schmidt, R.A., et al. Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol, 1999. 162: 352.

https://pubmed.ncbi.nlm.nih.gov/10411037/

274.Brazzelli, M., et al. Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review. J Urol, 2006. 175: 835.

https://pubmed.ncbi.nlm.nih.gov/16469561/

275.Groen, J., et al. Sacral neuromodulation as treatment for refractory idiopathic urge urinary incontinence: 5-year results of a longitudinal study in 60 women. J Urol, 2011. 186: 954.

https://pubmed.ncbi.nlm.nih.gov/21791355/

276.van Kerrebroeck, P.E., et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol, 2007. 178: 2029.

https://pubmed.ncbi.nlm.nih.gov/17869298/

277.Amundsen, C.L., et al. OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial. JAMA, 2016. 316: 1366.

https://pubmed.ncbi.nlm.nih.gov/27701661/

278.Siegel, S., et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn, 2015. 34: 224.

https://pubmed.ncbi.nlm.nih.gov/24415559/

279.Amundsen, C.L., et al. Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial. Eur Urol, 2018. 74: 66.

https://pubmed.ncbi.nlm.nih.gov/29482936/

280.Tutolo, M., et al. Efficacy and Safety of Sacral and Percutaneous Tibial Neuromodulation in Non-neurogenic Lower Urinary Tract Dysfunction and Chronic Pelvic Pain: A Systematic Review of the Literature. Eur Urol, 2018. 73: 406.

https://pubmed.ncbi.nlm.nih.gov/29336927/

281.Groenendijk, P.M., et al. Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence. BJU Int, 2008. 101: 325.

https://pubmed.ncbi.nlm.nih.gov/18070199/

282.Corcos, J., et al. The use of vaginal lasers in the treatment of urinary incontinence and overactive bladder, systematic review. Int Urogynecol J, 2021. 32: 553.

https://pubmed.ncbi.nlm.nih.gov/33175226/

283.Cody, J.D., et al. Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database Syst Rev, 2012: CD003306.

https://pubmed.ncbi.nlm.nih.gov/22336788/

284.Kockelbergh, R.C., et al. Clam enterocystoplasty in general urological practice. Br J Urol, 1991. 68: 38.

https://pubmed.ncbi.nlm.nih.gov/1873689/

285.Cohen, A.J., et al. Comparative Outcomes and Perioperative Complications of Robotic Vs Open Cystoplasty and Complex Reconstructions. Urology, 2016. 97: 172.

https://pubmed.ncbi.nlm.nih.gov/27443464/

286.Awad, S.A., et al. Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol, 1998. 81: 569.

https://pubmed.ncbi.nlm.nih.gov/9598629/

287.Lane, T., et al. Carcinoma following augmentation ileocystoplasty. Urol Int, 2000. 64: 31.

https://pubmed.ncbi.nlm.nih.gov/10782030/

288.Stone, A.R., et al. Carcinoma associated with augmentation cystoplasty. Br J Urol, 1987. 60: 236.

https://pubmed.ncbi.nlm.nih.gov/3676669/

289.Leedham, P.W., et al. Adenocarcinoma developing in an ileocystoplasty. Br J Surg, 1973. 60: 158.

https://pubmed.ncbi.nlm.nih.gov/4685940/

290.Biardeau, X., et al. Risk of malignancy after augmentation cystoplasty: A systematic review. Neurourol Urodyn, 2016. 35: 675.

https://pubmed.ncbi.nlm.nih.gov/25867054/

291.Greenwell, T.J., et al. Augmentation cystoplasty. BJU Int, 2001. 88: 511.

https://pubmed.ncbi.nlm.nih.gov/11678743/

292.Covert, W.M., et al. The role of mucoregulatory agents after continence-preserving urinary diversion surgery. Am J Health Syst Pharm, 2012. 69: 483.

https://pubmed.ncbi.nlm.nih.gov/22382478/

293.Padmanabhan, P., et al. Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity. World J Urol, 2011. 29: 51.

https://pubmed.ncbi.nlm.nih.gov/21110030/

294.Cartwright, P.C., et al. Bladder autoaugmentation: partial detrusor excision to augment the bladder without use of bowel. J Urol, 1989. 142: 1050.

https://pubmed.ncbi.nlm.nih.gov/2795729/

295.Leng, W.W., et al. Enterocystoplasty or detrusor myectomy? Comparison of indications and outcomes for bladder augmentation. J Urol, 1999. 161: 758.

https://pubmed.ncbi.nlm.nih.gov/10022679/

296.ter Meulen, P.H., et al. A study on the feasibility of vesicomyotomy in patients with motor urge incontinence. Eur Urol, 1997. 32: 166.

https://pubmed.ncbi.nlm.nih.gov/9286647/

297.Wu, J.M., et al. Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet Gynecol, 2009. 114: 1278.

https://pubmed.ncbi.nlm.nih.gov/19935030/

298.Hunskaar, S., et al. The prevalence of urinary incontinence in women in four European countries. BJU Int, 2004. 93: 324.

https://pubmed.ncbi.nlm.nih.gov/14764130/

299.Thom, D.H., et al. Differences in prevalence of urinary incontinence by race/ethnicity. J Urol, 2006. 175: 259.

https://pubmed.ncbi.nlm.nih.gov/16406923/

300.Mitchell, E.S., et al. Correlates of urinary incontinence during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women’s Health Study. Climacteric, 2013. 16: 653.

https://pubmed.ncbi.nlm.nih.gov/23560943/

301.Minassian, V.A., et al. Urinary incontinence in women: variation in prevalence estimates and risk factors. Obstet Gynecol, 2008. 111: 324.

https://pubmed.ncbi.nlm.nih.gov/18238969/

302.Brown, J.S., et al. Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol, 1996. 87: 715.

https://pubmed.ncbi.nlm.nih.gov/8677073/

303.Bø, K., et al. Is Physical Activity Good or Bad for the Female Pelvic Floor? A Narrative Review. Sports Med, 2020. 50: 471.

https://pubmed.ncbi.nlm.nih.gov/31820378/

304.DeLancey, J.O. Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am J Obstet Gynecol, 1994. 170: 1713.

https://pubmed.ncbi.nlm.nih.gov/8203431/

305.Aoki, Y., et al. Urinary incontinence in women. Nat Rev Dis Primers, 2017. 3: 17042.

https://pubmed.ncbi.nlm.nih.gov/28681849/

306.Hillary, C.J., et al. Considerations in the modern management of stress urinary incontinence resulting from intrinsic sphincter deficiency. World J Urol, 2015. 33: 1251.

https://pubmed.ncbi.nlm.nih.gov/26060138/

307.Medina, C.A., et al. Evaluation and surgery for stress urinary incontinence: A FIGO working group report. Neurourol Urodyn, 2017. 36: 518.

https://pubmed.ncbi.nlm.nih.gov/26950893/

308.Patnam, R., et al. Standing Vs Supine; Does it Matter in Cough Stress Testing? Female Pelvic Med Reconstr Surg, 2017. 23: 315.

https://pubmed.ncbi.nlm.nih.gov/28079569/

309.Guralnick, M.L., et al. ICS Educational Module: Cough stress test in the evaluation of female urinary incontinence: Introducing the ICS-Uniform Cough Stress Test. Neurourol Urodyn, 2018. 37: 1849.

https://pubmed.ncbi.nlm.nih.gov/29926966/

310.Rosier, P., et al. Committee 6: Urodynamic Testing, In: 5th International Consultation on Incontinence, Paris February, 2012, P. Abrams, L. Cardozo, S. Khoury & A. Wein, Editors. 2013: Paris, France.

https://www.worldcat.org/title/incontinence-5th-international-consultation-on-incontinence-paris-february-2012/oclc/859227786

311.Sirls, L.T., et al. The effect of urodynamic testing on clinical diagnosis, treatment plan and outcomes in women undergoing stress urinary incontinence surgery. J Urol, 2013. 189: 204.

https://pubmed.ncbi.nlm.nih.gov/22982425/

312.van Leijsen, S.A., et al. Can preoperative urodynamic investigation be omitted in women with stress urinary incontinence? A non-inferiority randomized controlled trial. Neurourol Urodyn, 2012. 31: 1118.

https://pubmed.ncbi.nlm.nih.gov/22488817/

313.van Leijsen, S.A., et al. Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial. Obstet Gynecol, 2013. 121: 999.

https://pubmed.ncbi.nlm.nih.gov/23635736/

314.Costantini, E., et al. Preoperative Valsalva leak point pressure may not predict outcome of
mid-urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid-urethral slings. Int Braz J Urol, 2008. 34: 73.

https://pubmed.ncbi.nlm.nih.gov/18341724/

315.Finazzi-Agrò, E., et al. Comments on “A randomized trial of urodynamic testing before stress-incontinence surgery” (N Engl J Med. 2012 May 24;366(21):1987-1997) From the Italian Society of Urodynamics. Neurourol Urodyn, 2013. 32: 301.

https://pubmed.ncbi.nlm.nih.gov/23023985/

316.Lewicky-Gaupp, C., et al. “The cough game”: are there characteristic urethrovesical movement patterns associated with stress incontinence? Int Urogynecol J Pelvic Floor Dysfunct, 2009. 20: 171.

https://pubmed.ncbi.nlm.nih.gov/18850057/

317.Shek, K.L., et al. The effect of childbirth on urethral mobility: a prospective observational study.
J Urol, 2010. 184: 629.

https://pubmed.ncbi.nlm.nih.gov/20639028/

318.Kociszewski, J., et al. Tape functionality: sonographic tape characteristics and outcome after TVT incontinence surgery. Neurourol Urodyn, 2008. 27: 485.

https://pubmed.ncbi.nlm.nih.gov/18288705/

319.Morgan, D.M., et al. Urethral sphincter morphology and function with and without stress incontinence. J Urol, 2009. 182: 203.

https://pubmed.ncbi.nlm.nih.gov/19450822/

320.Nguyen, L., et al. Surgical technique to overcome anatomical shortcoming: balancing post-prostatectomy continence outcomes of urethral sphincter lengths on preoperative magnetic resonance imaging. J Urol, 2008. 179: 1907.

https://pubmed.ncbi.nlm.nih.gov/18353395/

321.Nygaard, I., et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA, 2008.
300: 1311.

https://pubmed.ncbi.nlm.nih.gov/18799443/

322.Gozukara, Y.M., et al. The improvement in pelvic floor symptoms with weight loss in obese women does not correlate with the changes in pelvic anatomy. Int Urogynecol J, 2014. 25: 1219.

https://pubmed.ncbi.nlm.nih.gov/24711149/

323.Brown, J.S., et al. Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program. Diabetes Care, 2006. 29: 385.

https://pubmed.ncbi.nlm.nih.gov/16443892/

324.Bump, R.C., et al. Obesity and lower urinary tract function in women: effect of surgically induced weight loss. Am J Obstet Gynecol, 1992. 167: 392.

https://pubmed.ncbi.nlm.nih.gov/1497041/

325.Subak, L.L., et al. Does weight loss improve incontinence in moderately obese women? Int Urogynecol J Pelvic Floor Dysfunct, 2002. 13: 40.

https://pubmed.ncbi.nlm.nih.gov/11999205/

326.Wing, R.R., et al. Improving urinary incontinence in overweight and obese women through modest weight loss. Obstet Gynecol, 2010. 116: 284.

https://pubmed.ncbi.nlm.nih.gov/20664387/

327.Subak, L.L., et al. Weight loss: a novel and effective treatment for urinary incontinence. J Urol, 2005. 174: 190.

https://pubmed.ncbi.nlm.nih.gov/15947625/

328.Phelan, S., et al. Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial. J Urol, 2012. 187: 939.

https://pubmed.ncbi.nlm.nih.gov/22264468/

329.Burgio, K.L., et al. Changes in urinary and fecal incontinence symptoms with weight loss surgery in morbidly obese women. Obstet Gynecol, 2007. 110: 1034.

https://pubmed.ncbi.nlm.nih.gov/17978117/

330.Deitel, M., et al. Gynecologic-obstetric changes after loss of massive excess weight following bariatric surgery. J Am Coll Nutr, 1988. 7: 147.

https://pubmed.ncbi.nlm.nih.gov/3361039/

331.Laungani, R.G., et al. Effect of laparoscopic gastric bypass surgery on urinary incontinence in morbidly obese women. Surg Obes Relat Dis, 2009. 5: 334.

https://pubmed.ncbi.nlm.nih.gov/19342304/

332.Mishra, G.D., et al. Body weight through adult life and risk of urinary incontinence in middle-aged women: results from a British prospective cohort. Int J Obes (Lond), 2008. 32: 1415.

https://pubmed.ncbi.nlm.nih.gov/18626483/

333.Richter, H.E., et al. The impact of obesity on urinary incontinence symptoms, severity, urodynamic characteristics and quality of life. J Urol, 2010. 183: 622.

https://pubmed.ncbi.nlm.nih.gov/20018326/

334.Leshem, A., et al. Effects of Bariatric Surgery on Female Pelvic Floor Disorders. Urology, 2017. 105: 42.

https://pubmed.ncbi.nlm.nih.gov/28315786/

335.Knepfler, T., et al. Bariatric surgery improves female pelvic floor disorders. J Visc Surg, 2016. 153: 95.

https://pubmed.ncbi.nlm.nih.gov/26678846/

336.Subak, L.L., et al. Urinary Incontinence Before and After Bariatric Surgery. JAMA Intern Med, 2015. 175: 1378.

https://pubmed.ncbi.nlm.nih.gov/26098620/

337.Miller, J.M., et al. A pelvic muscle precontraction can reduce cough-related urine loss in selected women with mild SUI. J Am Geriatr Soc, 1998. 46: 870.

https://pubmed.ncbi.nlm.nih.gov/9670874/

338.Bø, K. Pelvic floor muscle training is effective in treatment of female stress urinary incontinence, but how does it work? Int Urogynecol J Pelvic Floor Dysfunct, 2004. 15: 76.

https://pubmed.ncbi.nlm.nih.gov/15014933/

339.Zubieta, M., et al. Influence of voluntary pelvic floor muscle contraction and pelvic floor muscle training on urethral closure pressures: a systematic literature review. Int Urogynecol J, 2016. 27: 687.

https://pubmed.ncbi.nlm.nih.gov/26407561/

340.Braekken, I.H., et al. Morphological changes after pelvic floor muscle training measured by 3-dimensional ultrasonography: a randomized controlled trial. Obstet Gynecol, 2010. 115: 317.

https://pubmed.ncbi.nlm.nih.gov/20093905/

341.Dumoulin, C., et al. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev, 2018. 10: CD005654.

https://pubmed.ncbi.nlm.nih.gov/30288727/

342.Herderschee, R., et al. Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev, 2011: CD009252.

https://pubmed.ncbi.nlm.nih.gov/21735442/

343.Hagen, S., et al. , Effectiveness and cost-effectiveness of biofeedback-assisted pelvic floor muscle training for female urinary incontinence: a multicentre randomised controlled trial (abstract 485), in ICS2019. 2019, ICS: Gothenburg, Sweden.

https://www.ics.org/2019/abstract/489

344.Dumoulin, C., et al. Group-Based vs Individual Pelvic Floor Muscle Training to Treat Urinary Incontinence in Older Women: A Randomized Clinical Trial. JAMA Intern Med, 2020. 180: 1284.

https://pubmed.ncbi.nlm.nih.gov/32744599/

345.Hay-Smith, E.J., et al. Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev, 2011: CD009508.

https://pubmed.ncbi.nlm.nih.gov/22161451/

346.Herbison, G.P., et al. Weighted vaginal cones for urinary incontinence. Cochrane Database Syst Rev, 2013. 2013: CD002114.

https://pubmed.ncbi.nlm.nih.gov/23836411/

347.Dumoulin, C., Committee 12, Conservative management, In: Incontinence, P. Abrams, L. Cardozo, A. Wagg, A. Wein, Eds. 2017.

https://www.ics.org/publications/ici_6/Incontinence_6th_Edition_2017_eBook_v2.pdf

348.Labrie, J., et al. Surgery versus physiotherapy for stress urinary incontinence. N Engl J Med, 2013. 369: 1124.

https://pubmed.ncbi.nlm.nih.gov/24047061/

349.Stewart, F., et al. Electrical stimulation with non-implanted devices for stress urinary incontinence in women. Cochrane Database Syst Rev, 2017. 12: CD012390.

https://pubmed.ncbi.nlm.nih.gov/29271482/

350.Mateus-Vasconcelos, E.C.L., et al. Effects of three interventions in facilitating voluntary pelvic floor muscle contraction in women: a randomized controlled trial. Braz J Phys Ther, 2018. 22: 391.

https://pubmed.ncbi.nlm.nih.gov/29429823/

351.Bø, K., et al. Does it work in the long term?--A systematic review on pelvic floor muscle training for female stress urinary incontinence. Neurourol Urodyn, 2013. 32: 215.

https://pubmed.ncbi.nlm.nih.gov/22847318/

352.Woodley, S.J., et al. Pelvic floor muscle training for preventing and treating urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev, 2020. 2020: CD007471.

https://pubmed.ncbi.nlm.nih.gov/32378735/

353.Sigurdardottir, T., et al. Can postpartum pelvic floor muscle training reduce urinary and anal incontinence?: An assessor-blinded randomized controlled trial. Am J Obstet Gynecol, 2020.
222: 247 e1.

https://pubmed.ncbi.nlm.nih.gov/31526791/

354.Wagg, A., et al. Committee 11, Incontinence in frail older persons, In: Incontinence, P. Abrams,
L. Cardozo, A. Wagg, A. Wein, Eds. 2017.

https://www.ics.org/publications/ici_6/Incontinence_6th_Edition_2017_eBook_v2.pdf

355.Stenzelius, K., et al. The effect of conservative treatment of urinary incontinence among older and frail older people: a systematic review. Age Ageing, 2015. 44: 736.

https://pubmed.ncbi.nlm.nih.gov/26112402/

356.Ayeleke, R.O., et al. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women. Cochrane Database Syst Rev, 2013.
11: CD010551.

https://pubmed.ncbi.nlm.nih.gov/24259154/

357.Gilling, P.J., et al. A double-blind randomized controlled trial of electromagnetic stimulation of the pelvic floor vs sham therapy in the treatment of women with stress urinary incontinence. BJU Int, 2009. 103: 1386.

https://pubmed.ncbi.nlm.nih.gov/19154474/

358.Lai, X., et al. Is electroacupuncture safe and effective for treatment of stress urinary incontinence in women? A systematic review and meta-analysis. J Int Med Res, 2020. 48: 300060520948337.

https://pubmed.ncbi.nlm.nih.gov/33045874/

359.Robinson, D., et al. Estrogens and the lower urinary tract. Neurourol Urodyn, 2011. 30: 754.

https://pubmed.ncbi.nlm.nih.gov/21661025/

360.Mettler, L., et al. Long-term treatment of atrophic vaginitis with low-dose oestradiol vaginal tablets. Maturitas, 1991. 14: 23.

https://pubmed.ncbi.nlm.nih.gov/1791769/

361.Weber, M.A., et al. Local Oestrogen for Pelvic Floor Disorders: A Systematic Review. PLoS One, 2015. 10: e0136265.

https://pubmed.ncbi.nlm.nih.gov/26383760/

362.Castellani, D., et al. Low-Dose Intravaginal Estriol and Pelvic Floor Rehabilitation in Post-Menopausal Stress Urinary Incontinence. Urol Int, 2015. 95: 417.

https://pubmed.ncbi.nlm.nih.gov/26043913/

363.Jackson, S., et al. The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial. Br J Obstet Gynaecol, 1999. 106: 711.

https://pubmed.ncbi.nlm.nih.gov/10428529/

364.Fantl, J.A., et al. Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group. Obstet Gynecol, 1996. 88: 745.

https://pubmed.ncbi.nlm.nih.gov/8885906/

365.Grady, D., et al. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol, 2001. 97: 116.

https://pubmed.ncbi.nlm.nih.gov/11152919/

366.Hendrix, S.L., et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA, 2005. 293: 935.

https://pubmed.ncbi.nlm.nih.gov/15728164/

367.Rossouw, J.E., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA, 2002. 288: 321.

https://pubmed.ncbi.nlm.nih.gov/12117397/

368.Steinauer, J.E., et al. Postmenopausal hormone therapy: does it cause incontinence? Obstet Gynecol, 2005. 106: 940.

https://pubmed.ncbi.nlm.nih.gov/16260510/

369.Goldstein, S.R., et al. Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen. Menopause, 2005. 12: 160.

https://pubmed.ncbi.nlm.nih.gov/15772563/

370.Molander, U., et al. Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause. Maturitas, 1990. 12: 113.

https://pubmed.ncbi.nlm.nih.gov/2255263/

371.Wang, C.J., et al. Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study. J Urol, 2011. 185: 219.

https://pubmed.ncbi.nlm.nih.gov/21074790/

372.Mariappan, P., et al. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol, 2007. 51: 67.

https://pubmed.ncbi.nlm.nih.gov/17014950/

373.Li, J., et al. The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis. Int Urol Nephrol, 2013. 45: 679.

https://pubmed.ncbi.nlm.nih.gov/23504618/

374.Ghoniem, G.M., et al. A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence.
J Urol, 2005. 173: 1647.

https://pubmed.ncbi.nlm.nih.gov/15821528/

375.Bump, R.C., et al. Long-term efficacy of duloxetine in women with stress urinary incontinence. BJU Int, 2008. 102: 214.

https://pubmed.ncbi.nlm.nih.gov/18422764/

376.Vella, M., et al. Duloxetine 1 year on: the long-term outcome of a cohort of women prescribed duloxetine. Int Urogynecol J Pelvic Floor Dysfunct, 2008. 19: 961.

https://pubmed.ncbi.nlm.nih.gov/18231697/

377.Maund, E., et al. Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports. CMAJ, 2017. 189: E194.

https://pubmed.ncbi.nlm.nih.gov/28246265/

378.Acharya, N., et al. Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. J Clin Psychopharmacol, 2006. 26: 587.

https://pubmed.ncbi.nlm.nih.gov/17110815/

379.Alhasso, A., et al. Adrenergic drugs for urinary incontinence in adults. Cochrane Database Syst Rev, 2005. 2010: CD001842.

https://pubmed.ncbi.nlm.nih.gov/16034867/

380.Cumberledge, J. First Do No Harm. The report of the Independent Medicines and Medical Devices Safety Review. 2020.

https://www.immdsreview.org.uk/downloads/IMMDSReview_Web.pdf

381.Chapple, C.R., et al. Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary Incontinence. Eur Urol, 2017. 72: 424.

https://pubmed.ncbi.nlm.nih.gov/28413126/

382.Brazzelli, M., et al. Surgical treatments for women with stress urinary incontinence: the ESTER systematic review and economic evaluation. Health Technol Assess, 2019. 23: 1.

https://pubmed.ncbi.nlm.nih.gov/30929658/

383.Javanbakht, M., et al. Surgical treatments for women with stress urinary incontinence: a systematic review of economic evidence. Syst Rev, 2020. 9: 85.

https://pubmed.ncbi.nlm.nih.gov/32312310/

384.Franzen, K., et al. Surgery for urinary incontinence in women 65 years and older: a systematic review. Int Urogynecol J, 2015. 26: 1095.

https://pubmed.ncbi.nlm.nih.gov/25477140/

385.Freites, J., et al. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev, 2019. 12: CD002239.

https://pubmed.ncbi.nlm.nih.gov/31821550/

386.Glazener, C.M., et al. Anterior vaginal repair for urinary incontinence in women. Cochrane Database Syst Rev, 2017. 7: CD001755.

https://pubmed.ncbi.nlm.nih.gov/28759116/

387.Lapitan, M.C., et al. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev, 2016. 2: CD002912.

https://pubmed.ncbi.nlm.nih.gov/26878400/

388.Sarma, A.V., et al. Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study. Urology, 2009. 73: 1203.

https://pubmed.ncbi.nlm.nih.gov/19362350/

389.Gumus, II, et al. Laparoscopic single-port Burch colposuspension with an extraperitoneal approach and standard instruments for stress urinary incontinence: early results from a series of 15 patients. Minim Invasive Ther Allied Technol, 2013. 22: 116.

https://pubmed.ncbi.nlm.nih.gov/22909022/

390.Guerrero, K.L., et al. A randomised controlled trial comparing TVT, Pelvicol and autologous fascial slings for the treatment of stress urinary incontinence in women. BJOG, 2010. 117: 1493.

https://pubmed.ncbi.nlm.nih.gov/20939862/

391.Brubaker, L., et al. 5-year continence rates, satisfaction and adverse events of burch urethropexy and fascial sling surgery for urinary incontinence. J Urol, 2012. 187: 1324.

https://pubmed.ncbi.nlm.nih.gov/22341290/

392.Kirchin, V., et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev, 2012: CD003881.

https://pubmed.ncbi.nlm.nih.gov/22336797/

393.Kirchin, V., et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev, 2017. 7: CD003881.

https://pubmed.ncbi.nlm.nih.gov/28738443/

394.Davis, N.F., et al. Injectable biomaterials for the treatment of stress urinary incontinence: their potential and pitfalls as urethral bulking agents. Int Urogynecol J, 2013. 24: 913.

https://pubmed.ncbi.nlm.nih.gov/23224022/

395.Ghoniem, G.M., et al. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence. Int Urogynecol J, 2013. 24: 27.

https://pubmed.ncbi.nlm.nih.gov/22699885/

396.Kasi, A.D., et al. Polyacrylamide hydrogel (Bulkamid(R)) for stress urinary incontinence in women: a systematic review of the literature. Int Urogynecol J, 2016. 27: 367.

https://pubmed.ncbi.nlm.nih.gov/26209952/

397.Siddiqui, Z.A., et al. Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review. Int Urogynecol J, 2017. 28: 1275.

https://pubmed.ncbi.nlm.nih.gov/28220200/

398.Matsuoka, P.K., et al. The efficacy and safety of urethral injection therapy for urinary incontinence in women: a systematic review. Clinics (Sao Paulo), 2016. 71: 94.

https://pubmed.ncbi.nlm.nih.gov/26934239/

399.Zhao, Y., et al. Bulking agents - an analysis of 500 cases and review of the literature. Clin Exp Obstet Gynecol, 2016. 43: 666.

https://pubmed.ncbi.nlm.nih.gov/30074316/

400.Lee, P.E., et al. Periurethral autologous fat injection as treatment for female stress urinary incontinence: a randomized double-blind controlled trial. J Urol, 2001. 165: 153.

https://pubmed.ncbi.nlm.nih.gov/11125386/

401.Schulz, J.A., et al. Bulking agents for stress urinary incontinence: short-term results and complications in a randomized comparison of periurethral and transurethral injections. Int Urogynecol J Pelvic Floor Dysfunct, 2004. 15: 261.

https://pubmed.ncbi.nlm.nih.gov/15517671/

402.Kuhn, A., et al. Where should bulking agents for female urodynamic stress incontinence be injected? Int Urogynecol J Pelvic Floor Dysfunct, 2008. 19: 817.

https://pubmed.ncbi.nlm.nih.gov/18157642/

403.Krhut, J., et al. Treatment of stress urinary incontinence using polyacrylamide hydrogel in women after radiotherapy: 1-year follow-up. Int Urogynecol J, 2016. 27: 301.

https://pubmed.ncbi.nlm.nih.gov/26342812/

404.Carr, L.K., et al. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study. J Urol, 2013. 189: 595.

https://pubmed.ncbi.nlm.nih.gov/23260547/

405.Maher, C.F., et al. Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial. BJOG, 2005. 112: 797.

https://pubmed.ncbi.nlm.nih.gov/15924540/

406.Itkonen Freitas, A.M., et al. Tension-Free Vaginal Tape Surgery versus Polyacrylamide Hydrogel Injection for Primary Stress Urinary Incontinence: A Randomized Clinical Trial. J Urol, 2020. 203: 372.

https://pubmed.ncbi.nlm.nih.gov/31479396/

407.Pivazyan, L., et al. Effectiveness and safety of bulking agents versus surgical methods in women with stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J, 2021.

https://pubmed.ncbi.nlm.nih.gov/34351463/

408.Wang, Y., et al. Safety and efficacy of vaginal laser therapy for stress urinary incontinence: a meta-analysis. Ann Palliative Med, 2021. 10: 2736.

https://pubmed.ncbi.nlm.nih.gov/33549008/

409.Abrams, P., et al. Synthetic vaginal tapes for stress incontinence: proposals for improved regulation of new devices in Europe. Eur Urol, 2011. 60: 1207.

https://pubmed.ncbi.nlm.nih.gov/21855204/

410.Ford, A.A., et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev, 2017. 7: CD006375.

https://pubmed.ncbi.nlm.nih.gov/28756647/

411.Albo, M.E., et al. Treatment success of retropubic and transobturator mid urethral slings at
24 months. J Urol, 2012. 188: 2281.

https://pubmed.ncbi.nlm.nih.gov/23083653/

412.Kenton, K., et al. 5-year longitudinal followup after retropubic and transobturator mid urethral slings. J Urol, 2015. 193: 203.

https://pubmed.ncbi.nlm.nih.gov/25158274/

413.Serati, M., et al. Tension-free Vaginal Tape-Obturator for Treatment of Pure Urodynamic Stress Urinary Incontinence: Efficacy and Adverse Effects at 10-year Follow-up. Eur Urol, 2017. 71: 674.

https://pubmed.ncbi.nlm.nih.gov/27597239/

414.Svenningsen, R., et al. Long-term follow-up of the retropubic tension-free vaginal tape procedure. Int Urogynecol J, 2013. 24: 1271.

https://pubmed.ncbi.nlm.nih.gov/23417313/

415.Natale, F., et al. Transobturator Tape: Over 10 Years Follow-up. Urology, 2019. 129: 48.

https://pubmed.ncbi.nlm.nih.gov/30890420/

416.Nilsson, C.G., et al. Seventeen years’ follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. Int Urogynecol J, 2013. 24: 1265.

https://pubmed.ncbi.nlm.nih.gov/23563892/

417.Lier, D., et al. Surgical treatment of stress urinary incontinence-trans-obturator tape compared with tension-free vaginal tape-5-year follow up: an economic evaluation. BJOG, 2017. 124: 1431.

https://pubmed.ncbi.nlm.nih.gov/27506185/

418.Ford, A.A., et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev, 2015: CD006375.

https://pubmed.ncbi.nlm.nih.gov/26130017/

419.Fusco, F., et al. Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence. Eur Urol, 2017. 72: 567.

https://pubmed.ncbi.nlm.nih.gov/28479203/

420.Cheung, R.Y., et al. Inside-out versus outside-in transobturator tension-free vaginal tape: a 5-year prospective comparative study. Int J Urol, 2014. 21: 74.

https://pubmed.ncbi.nlm.nih.gov/23675961/

421.Abdel-Fattah, M., et al. Long-term outcomes for transobturator tension-free vaginal tapes in women with urodynamic mixed urinary incontinence. Neurourol Urodyn, 2017. 36: 902.

https://pubmed.ncbi.nlm.nih.gov/28028822/

422.Morling, J.R., et al. Adverse events after first, single, mesh and non-mesh surgical procedures for stress urinary incontinence and pelvic organ prolapse in Scotland, 1997-2016: a population-based cohort study. Lancet, 2017. 389: 629.

https://pubmed.ncbi.nlm.nih.gov/28010993/

423.Keltie, K., et al. Complications following vaginal mesh procedures for stress urinary incontinence: an 8 year study of 92,246 women. Sci Rep, 2017. 7: 12015.

https://pubmed.ncbi.nlm.nih.gov/28931856/

424.Morton, S., et al. Complications of synthetic mesh inserted for stress urinary incontinence. BJU Int, 2021. 127: 4.

https://pubmed.ncbi.nlm.nih.gov/32981191/

425.Alwaal, A., et al. Female sexual function following mid-urethral slings for the treatment of stress urinary incontinence. Int J Impot Res, 2016. 28: 121.

https://pubmed.ncbi.nlm.nih.gov/27146350/

426.Fan, Y., et al. Incontinence-specific quality of life measures used in trials of sling procedures for female stress urinary incontinence: a meta-analysis. Int Urol Nephrol, 2015. 47: 1277.

https://pubmed.ncbi.nlm.nih.gov/26093584/

427.Wyndaele, J.J., et al. A randomized, controlled clinical trial of an intravesical pressure-attenuation balloon system for the treatment of stress urinary incontinence in females. Neurourol Urodyn, 2016. 35: 252.

https://pubmed.ncbi.nlm.nih.gov/25598453/

428.McCammon, K., et al. Three-month primary efficacy data for the SUCCESS Trial; a phase III, multi-center, prospective, randomized, controlled study treating female stress urinary incontinence with the vesair intravesical balloon. Neurourol Urodyn, 2018. 37: 440.

https://pubmed.ncbi.nlm.nih.gov/29095516/

429.Winkler, H., et al. Twelve-Month Efficacy and Safety Data for the “Stress Incontinence Control, Efficacy and Safety Study”: A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical Balloon. Female Pelvic Med Reconstr Surg, 2018. 24: 222.

https://pubmed.ncbi.nlm.nih.gov/28953076/

430.Lipp, A., et al. Mechanical devices for urinary incontinence in women. Cochrane Database Syst Rev, 2014. 2014: CD001756.

https://pubmed.ncbi.nlm.nih.gov/25517397/

431.Shaikh, S., et al. Mechanical devices for urinary incontinence in women. Cochrane Database Syst Rev, 2006: CD001756.

https://pubmed.ncbi.nlm.nih.gov/16855977/

432.Phé, V., et al. A systematic review of the treatment for female stress urinary incontinence by ACT® balloon placement (Uromedica, Irvine, CA, USA). World J Urol, 2014. 32: 495.

https://pubmed.ncbi.nlm.nih.gov/23783882/

433.Peyronnet, B., et al. AMS-800 Artificial urinary sphincter in female patients with stress urinary incontinence: A systematic review. Neurourol Urodyn, 2019. 38 Suppl 4: S28.

https://pubmed.ncbi.nlm.nih.gov/30298943/

434.Bakali, E., et al. Treatment of recurrent stress urinary incontinence after failed minimally invasive synthetic suburethral tape surgery in women. Cochrane Database Syst Rev, 2013: CD009407.

https://pubmed.ncbi.nlm.nih.gov/23450602/

435.Zimmern, P.E., et al. Management of recurrent stress urinary incontinence after burch and sling procedures. Neurourol Urodyn, 2016. 35: 344.

https://pubmed.ncbi.nlm.nih.gov/25598512/

436.Bakali, E., et al. Interventions for treating recurrent stress urinary incontinence after failed minimally invasive synthetic midurethral tape surgery in women. Cochrane Database Syst Rev, 2019.
9: CD009407.

https://pubmed.ncbi.nlm.nih.gov/31482580/

437.Pradhan, A., et al. Effectiveness of midurethral slings in recurrent stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J, 2012. 23: 831.

https://pubmed.ncbi.nlm.nih.gov/22576328/

438.Agur, W., et al. Surgical treatment of recurrent stress urinary incontinence in women: a systematic review and meta-analysis of randomised controlled trials. Eur Urol, 2013. 64: 323.

https://pubmed.ncbi.nlm.nih.gov/23680414/

439.Nikolopoulos, K.I., et al. The surgical management of recurrent stress urinary incontinence: a systematic review. Acta Obstet Gynecol Scand, 2015. 94: 568.

https://pubmed.ncbi.nlm.nih.gov/25737292/

440.Amaye-Obu, F.A., et al. Surgical management of recurrent stress urinary incontinence: A 12-year experience. Am J Obstet Gynecol, 1999. 181: 1296.

https://pubmed.ncbi.nlm.nih.gov/10601904/

441.Errando-Smet, C., et al. A re-adjustable sling for female recurrent stress incontinence and intrinsic sphincteric deficiency: Long-term results in 205 patients using the Remeex sling system. Neurourol Urodyn, 2018. 37: 1349.

https://pubmed.ncbi.nlm.nih.gov/29130569/

442.Chung, E., et al. 25-year experience in the outcome of artificial urinary sphincter in the treatment of female urinary incontinence. BJU Int, 2010. 106: 1664.

https://pubmed.ncbi.nlm.nih.gov/20500509/

443.Costa, P., et al. The use of an artificial urinary sphincter in women with type III incontinence and a negative Marshall test. J Urol, 2001. 165: 1172.

https://pubmed.ncbi.nlm.nih.gov/11257664/

444.Heitz, M., et al. [Therapy of female urinary incontinence with the AMS 800 artificial sphincter. Indications, outcome, complications and risk factors]. Urologe A, 1997. 36: 426.

https://pubmed.ncbi.nlm.nih.gov/9424794/

445.Vayleux, B., et al. Female urinary incontinence and artificial urinary sphincter: study of efficacy and risk factors for failure and complications. Eur Urol, 2011. 59: 1048.

https://pubmed.ncbi.nlm.nih.gov/21420781/

446.Mandron, E., et al. Laparoscopic artificial urinary sphincter implantation for female genuine stress urinary incontinence: technique and 4-year experience in 25 patients. BJU Int, 2010. 106: 1194.

https://pubmed.ncbi.nlm.nih.gov/20132197/

447.Roupret, M., et al. Laparoscopic approach for artificial urinary sphincter implantation in women with intrinsic sphincter deficiency incontinence: a single-centre preliminary experience. Eur Urol, 2010. 57: 499.

https://pubmed.ncbi.nlm.nih.gov/19346059/

448.Brennand, E.A., et al. Five years after midurethral sling surgery for stress incontinence: obesity continues to have an impact on outcomes. Int Urogynecol J, 2017. 28: 621.

https://pubmed.ncbi.nlm.nih.gov/27686569/

449.Brennand, E.A., et al. Twelve-month outcomes following midurethral sling procedures for stress incontinence: impact of obesity. BJOG, 2015. 122: 1705.

https://pubmed.ncbi.nlm.nih.gov/25316484/

450.Moore, R.D., et al. Two-year evaluation of the MiniArc in obese versus non-obese patients for treatment of stress urinary incontinence. Int J Urol, 2013. 20: 434.

https://pubmed.ncbi.nlm.nih.gov/22989174/

451.Rechberger, T., et al. The clinical effectiveness of retropubic (IVS-02) and transobturator (IVS-04) midurethral slings: randomized trial. Eur Urol, 2009. 56: 24.

https://pubmed.ncbi.nlm.nih.gov/19285788/

452.Barber, M.D., et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. Am J Obstet Gynecol, 2008. 199: 666 e1.

https://pubmed.ncbi.nlm.nih.gov/19084098/

453.Richter, H.E., et al. Predictors of treatment failure 24 months after surgery for stress urinary incontinence. J Urol, 2008. 179: 1024.

https://pubmed.ncbi.nlm.nih.gov/18206917/

454.Campeau, L., et al. A multicenter, prospective, randomized clinical trial comparing tension-free vaginal tape surgery and no treatment for the management of stress urinary incontinence in elderly women. Neurourol Urodyn, 2007. 26: 990.

https://pubmed.ncbi.nlm.nih.gov/17638307/

455.Serati, M., et al. Transobturator vaginal tape for the treatment of stress urinary incontinence in elderly women without concomitant pelvic organ prolapse: is it effective and safe? Eur J Obstet Gynecol Reprod Biol, 2013. 166: 107.

https://pubmed.ncbi.nlm.nih.gov/23164504/

456.Groutz, A., et al. The safety and efficacy of the “inside-out” trans-obturator TVT in elderly versus younger stress-incontinent women: a prospective study of 353 consecutive patients. Neurourol Urodyn, 2011. 30: 380.

https://pubmed.ncbi.nlm.nih.gov/20665549/

457.Chughtai, B., et al. Diagnosis, Evaluation, and Treatment of Mixed Urinary Incontinence in Women. Rev Urol, 2015. 17: 78.

https://pubmed.ncbi.nlm.nih.gov/27222643/

458.Incontinence, P. Abrams, Cardozo, L, Wagg, A, Wein, A. (Eds). 2017, Bristol, UK.

https://www.ics.org/publications/ici_6/Incontinence_6th_Edition_2017_eBook_v2.pdf

459.Minassian, V.A., et al. Severity of urinary incontinence and effect on quality of life in women by incontinence type. Obstet Gynecol, 2013. 121: 1083.

https://pubmed.ncbi.nlm.nih.gov/23635747/

460.Brubaker, L., et al. Mixed incontinence: comparing definitions in women having stress incontinence surgery. Neurourol Urodyn, 2009. 28: 268.

https://pubmed.ncbi.nlm.nih.gov/19274758/

461.Porena, M., et al. Mixed Incontinence: How Best to Manage It? Curr Bladder Dysfunct Rep, 2013.
8: 7.

https://pubmed.ncbi.nlm.nih.gov/23396610/

462.Jung, S.Y., et al. Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. J Urol, 1999. 162: 204.

https://pubmed.ncbi.nlm.nih.gov/10379788/

463.Mahony, D.T., et al. Integral storage and voiding reflexes. Neurophysiologic concept of continence and micturition. Urology, 1977. 9: 95.

https://pubmed.ncbi.nlm.nih.gov/556658/

464.Nygaard, I.E. Evidence-Based Treatment for Mixed Urinary Incontinence. JAMA, 2019. 322: 1049.

https://pubmed.ncbi.nlm.nih.gov/31528991/

465.Myers, D.L. Female mixed urinary incontinence: a clinical review. JAMA, 2014. 311: 2007.

https://pubmed.ncbi.nlm.nih.gov/24846038/

466.Nygaard, I.E., et al. Efficacy of pelvic floor muscle exercises in women with stress, urge, and mixed urinary incontinence. Am J Obstet Gynecol, 1996. 174: 120.

https://pubmed.ncbi.nlm.nih.gov/8571994/

467.Sar, D., et al. The effects of pelvic floor muscle training on stress and mixed urinary incontinence and quality of life. J Wound Ostomy Continence Nurs, 2009. 36: 429.

https://pubmed.ncbi.nlm.nih.gov/19609165/

468.Celiker Tosun, O., et al. Does pelvic floor muscle training abolish symptoms of urinary incontinence? A randomized controlled trial. Clin Rehabil, 2015. 29: 525.

https://pubmed.ncbi.nlm.nih.gov/25142280/

469.Liu, B., et al. Electroacupuncture Versus Pelvic Floor Muscle Training Plus Solifenacin for Women With Mixed Urinary Incontinence: A Randomized Noninferiority Trial. Mayo Clin Proc, 2019. 94: 54.

https://pubmed.ncbi.nlm.nih.gov/30611454/

470.Sung, V.W., et al. Effect of Behavioral and Pelvic Floor Muscle Therapy Combined With Surgery vs Surgery Alone on Incontinence Symptoms Among Women With Mixed Urinary Incontinence: The ESTEEM Randomized Clinical Trial. JAMA, 2019. 322: 1066.

https://pubmed.ncbi.nlm.nih.gov/31529007/

471.Kaya, S., et al. Short-term effect of adding pelvic floor muscle training to bladder training for female urinary incontinence: a randomized controlled trial. Int Urogynecol J, 2015. 26: 285.

https://pubmed.ncbi.nlm.nih.gov/25266357/

472.Khullar, V., et al. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. Urology, 2004. 64: 269.

https://pubmed.ncbi.nlm.nih.gov/15302476/

473.Kreder, K.J., Jr., et al. Tolterodine is equally effective in patients with mixed incontinence and those with urge incontinence alone. BJU Int, 2003. 92: 418.

https://pubmed.ncbi.nlm.nih.gov/12930432/

474.Kelleher, C., et al. Solifenacin: as effective in mixed urinary incontinence as in urge urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct, 2006. 17: 382.

https://pubmed.ncbi.nlm.nih.gov/16283422/

475.Staskin, D.R., et al. Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence. BJU Int, 2006. 97: 1256.

https://pubmed.ncbi.nlm.nih.gov/16686722/

476.Bent, A.E., et al. Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence. Neurourol Urodyn, 2008. 27: 212.

https://pubmed.ncbi.nlm.nih.gov/17580357/

477.Bump, R.C., et al. Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response. Obstet Gynecol, 2003. 102: 76.

https://pubmed.ncbi.nlm.nih.gov/12850610/

478.Shirvan, M.K., et al. Tension-Free Vaginal Tape Plus Intradetrusor BOTOX® Injection Versus Tension-Free Vaginal Tape Versus Intradetrusor BOTOX Injection in Equal-Weight Mixed Urinary Incontinence: A Prospective Randomized Study. J Gynecol Surg, 2013. 29: 235.

https://www.researchgate.net/publication/257307558

479.Kuo, H.C. Effect of detrusor function on the therapeutic outcome of a suburethral sling procedure using a polypropylene sling for stress urinary incontinence in women. Scand J Urol Nephrol, 2007. 41: 138.

https://pubmed.ncbi.nlm.nih.gov/17454953/

480.Colombo, M., et al. The Burch colposuspension for women with and without detrusor overactivity. Br J Obstet Gynaecol, 1996. 103: 255.

https://pubmed.ncbi.nlm.nih.gov/8630311/

481.Kulseng-Hanssen, S., et al. The tension free vaginal tape operation for women with mixed incontinence: Do preoperative variables predict the outcome? Neurourol Urodyn, 2007. 26: 115.

https://pubmed.ncbi.nlm.nih.gov/16894616/

482.Kulseng-Hanssen, S., et al. Follow-up of TVT operations in 1,113 women with mixed urinary incontinence at 7 and 38 months. Int Urogynecol J Pelvic Floor Dysfunct, 2008. 19: 391.

https://pubmed.ncbi.nlm.nih.gov/17891326/

483.Sung, V.W., et al. Methods for a multicenter randomized trial for mixed urinary incontinence: rationale and patient-centeredness of the ESTEEM trial. Int Urogynecol J, 2016. 27: 1479.

https://pubmed.ncbi.nlm.nih.gov/27287818/

484.Han, J.Y., et al. Effectiveness of retropubic tension-free vaginal tape and transobturator inside-out tape procedures in women with overactive bladder and stress urinary incontinence. Int Neurourol J, 2013. 17: 145.

https://pubmed.ncbi.nlm.nih.gov/24143294/

485.Natale, F., et al. Mixed urinary incontinence: A prospective study on the effect of trans-obturator mid-urethral sling. Eur J Obstet Gynecol Reprod Biol, 2018. 221: 64.

https://pubmed.ncbi.nlm.nih.gov/29248808/

486.Chapple, C.R., et al. Terminology report from the International Continence Society (ICS) Working Group on Underactive Bladder (UAB). Neurourol Urodyn, 2018. 37: 2928.

https://pubmed.ncbi.nlm.nih.gov/30203560/

487.Resnick, N.M., et al. The pathophysiology of urinary incontinence among institutionalized elderly persons. N Engl J Med, 1989. 320: 1.

https://pubmed.ncbi.nlm.nih.gov/2909873/

488.Abarbanel, J., et al. Impaired detrusor contractility in community-dwelling elderly presenting with lower urinary tract symptoms. Urology, 2007. 69: 436.

https://pubmed.ncbi.nlm.nih.gov/17382138/

489.Groutz, A., et al. Prevalence and characteristics of voiding difficulties in women: are subjective symptoms substantiated by objective urodynamic data? Urology, 1999. 54: 268.

https://pubmed.ncbi.nlm.nih.gov/10443723/

490.Jeong, S.J., et al. Prevalence and Clinical Features of Detrusor Underactivity among Elderly with Lower Urinary Tract Symptoms: A Comparison between Men and Women. Korean J Urol, 2012.
53: 342.

https://pubmed.ncbi.nlm.nih.gov/22670194/

491.Valente, S., et al. Epidemiology and demographics of the underactive bladder: a cross-sectional survey. Int Urol Nephrol, 2014. 46 Suppl 1: S7.

https://pubmed.ncbi.nlm.nih.gov/25238889/

492.Cohn, J.A., et al. Underactive bladder in women: is there any evidence? Curr Opin Urol, 2016.
26: 309.

https://pubmed.ncbi.nlm.nih.gov/26927630/

493.Madersbacher, H., et al. What are the causes and consequences of bladder overdistension? ICI-RS 2011. Neurourol Urodyn, 2012. 31: 317.

https://pubmed.ncbi.nlm.nih.gov/22419355/

494.Suskind, A.M., et al. A new look at detrusor underactivity: impaired contractility versus afferent dysfunction. Curr Urol Rep, 2009. 10: 347.

https://pubmed.ncbi.nlm.nih.gov/19709481/

495.Abdel Raheem, A., et al. Voiding dysfunction in women: How to manage it correctly. Arab J Urol, 2013. 11: 319.

https://pubmed.ncbi.nlm.nih.gov/26558099/

496.Jiang, Y.H., et al. Urothelial Barrier Deficits, Suburothelial Inflammation and Altered Sensory Protein Expression in Detrusor Underactivity. J Urol, 2017. 197: 197.

https://pubmed.ncbi.nlm.nih.gov/27436428/

497.Gammie, A., et al. Signs and Symptoms of Detrusor Underactivity: An Analysis of Clinical Presentation and Urodynamic Tests From a Large Group of Patients Undergoing Pressure Flow Studies. Eur Urol, 2016. 69: 361.

https://pubmed.ncbi.nlm.nih.gov/26318706/

498.Uren, A.D., et al. Qualitative Exploration of the Patient Experience of Underactive Bladder. Eur Urol, 2017. 72: 402.

https://pubmed.ncbi.nlm.nih.gov/28400168/

499.Uren, A.D., et al. The development of the ICIQ-UAB: A patient reported outcome measure for underactive bladder. Neurourol Urodyn, 2019. 38: 996.

https://pubmed.ncbi.nlm.nih.gov/30801826/

500.Kira, S., et al. Detrusor pressures in urodynamic studies during voiding in women. Int Urogynecol J, 2017. 28: 783.

https://pubmed.ncbi.nlm.nih.gov/27999934/

501.Osman, N.I., et al. Detrusor Underactivity and the Underactive Bladder: A Systematic Review of Preclinical and Clinical Studies. Eur Urol, 2018. 74: 633.

https://pubmed.ncbi.nlm.nih.gov/30139634/

502.Jeong, S.J., et al. How do we diagnose detrusor underactivity? Comparison of diagnostic criteria based on an urodynamic measure. Investig Clin Urol, 2017. 58: 247.

https://pubmed.ncbi.nlm.nih.gov/28681034/

503.Griffiths, D.J., et al. Urinary bladder function and its control in healthy females. Am J Physiol, 1986. 251: R225.

https://pubmed.ncbi.nlm.nih.gov/3740303/

504.Abrams, P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int, 1999. 84: 14.

https://pubmed.ncbi.nlm.nih.gov/10444116/

505.Tan, T.L., et al. Stop test or pressure-flow study? Measuring detrusor contractility in older females. Neurourol Urodyn, 2004. 23: 184.

https://pubmed.ncbi.nlm.nih.gov/15098212/

506.Tan, T.L., et al. Which stop test is best? Measuring detrusor contractility in older females. J Urol, 2003. 169: 1023.

https://pubmed.ncbi.nlm.nih.gov/12576837/

507.Griffiths, D.J. Assessment of detrusor contraction strength or contractility. Neurourol Urodyn, 1991. 10: 1.

https://onlinelibrary.wiley.com/doi/abs/10.1002/nau.1930100102

508.van Koeveringe, G.A., et al. Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. Neurourol Urodyn, 2011. 30: 723.

https://pubmed.ncbi.nlm.nih.gov/21661020/

509.Schäfer, W. Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple. World J Urol, 1995. 13: 47.

https://pubmed.ncbi.nlm.nih.gov/7773317/

510.Ameda, K., et al. The long-term voiding function and sexual function after pelvic nerve-sparing radical surgery for rectal cancer. Int J Urol, 2005. 12: 256.

https://pubmed.ncbi.nlm.nih.gov/15828952/

511.Espino-Strebel, E.E., et al. A comparison of the feasibility and safety of nerve-sparing radical hysterectomy with the conventional radical hysterectomy. Int J Gynecol Cancer, 2010. 20: 1274.

https://pubmed.ncbi.nlm.nih.gov/21495251/

512.Salvatore S, et al. Pathophysiology of urinary incontinence, faecal incontinence and pelvic organ prolapse, In: Incontinence C.L. Abrams P, Wagg A, Wein A, Editor. 2017, ICS-ICUD.

https://www.ics.org/publications/ici_6/Incontinence_6th_Edition_2017_eBook_v2.pdf

513.El Akri, M., et al. Risk of prolapse and urinary complications in adult spina bifida patients with neurogenic acontractile detrusor using clean intermittent catheterization versus Valsalva voiding. Neurourol Urodyn, 2019. 38: 269.

https://pubmed.ncbi.nlm.nih.gov/30311685/

514.Naess, I., et al. Can maximal voluntary pelvic floor muscle contraction reduce vaginal resting pressure and resting EMG activity? Int Urogynecol J, 2018. 29: 1623.

https://pubmed.ncbi.nlm.nih.gov/29532122/

515.Mercier, J., et al. Pelvic floor muscle training: mechanisms of action for the improvement of genitourinary syndrome of menopause. Climacteric, 2020. 23: 468.

https://pubmed.ncbi.nlm.nih.gov/32105155/

516.Ladi-Seyedian, S., et al. Management of non-neuropathic underactive bladder in children with voiding dysfunction by animated biofeedback: a randomized clinical trial. Urology, 2015. 85: 205.

https://pubmed.ncbi.nlm.nih.gov/25444633/

517.Apostolidis A, et al. Neurological Urinary and fecal incontinence, In: Incontinence, C.L. Abrams P, Wagg A, Wein A,, Editor. 2017, ICS ICUD.

https://www.ics.org/publications/ici_6/Incontinence_6th_Edition_2017_eBook_v2.pdf

518.Huber, E.R., et al. [The value of intravesical electrostimulation in the treatment of acute prolonged bladder overdistension]. Urologe A, 2007. 46: 662.

https://pubmed.ncbi.nlm.nih.gov/17356837/

519.Hartigan, S.M., et al. The inFlow intraurethral valve-pump for women with detrusor underactivity: A summary of peer-reviewed literature. J Spinal Cord Med, 2020.

https://pubmed.ncbi.nlm.nih.gov/33054612/

520.Barendrecht, M.M., et al. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int, 2007. 99: 749.

https://pubmed.ncbi.nlm.nih.gov/17233798/

521.Chang, S.J., et al. The effectiveness of tamsulosin in treating women with voiding difficulty. Int
J Urol, 2008. 15: 981.

https://pubmed.ncbi.nlm.nih.gov/18721208/

522.Costantini, E., et al. Open-label, longitudinal study of tamsulosin for functional bladder outlet obstruction in women. Urol Int, 2009. 83: 311.

https://pubmed.ncbi.nlm.nih.gov/19829032/

523.Yamanishi, T., et al. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol, 2004. 11: 88.

https://pubmed.ncbi.nlm.nih.gov/14706012/

524.Buckley, B.S., et al. Drugs for treatment of urinary retention after surgery in adults. Cochrane Database Syst Rev, 2010: CD008023.

https://pubmed.ncbi.nlm.nih.gov/20927768/

525.Jonas, U., et al. Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol, 2001. 165: 15.

https://pubmed.ncbi.nlm.nih.gov/11125353/

526.Gross, C., et al. Sacral neuromodulation for nonobstructive urinary retention: a meta-analysis. Female Pelvic Med Reconstr Surg, 2010. 16: 249.

https://pubmed.ncbi.nlm.nih.gov/22453352/

527.Gani, J., et al. The underactive bladder: diagnosis and surgical treatment options. Transl Androl Urol, 2017. 6: S186.

https://pubmed.ncbi.nlm.nih.gov/28791238/

528.Swinn, M.J., et al. Sacral neuromodulation for women with Fowler’s syndrome. Eur Urol, 2000.
38: 439.

https://pubmed.ncbi.nlm.nih.gov/11025383/

529.Panicker, J.N., et al. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol, 2015. 14: 720.

https://pubmed.ncbi.nlm.nih.gov/26067125/

530.Kuo, H.C. Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction. Urology, 2007. 69: 57.

https://pubmed.ncbi.nlm.nih.gov/17270614/

531.Kuo, H.C. Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity. Urology, 2003. 61: 550.

https://pubmed.ncbi.nlm.nih.gov/12639645/

532.Lee, Y.-K., et al. Therapeutic Efficacy and Quality of Life Improvement in Women with Detrusor Underactivity Following Transurethral Incision of the Bladder Ne. Urol Sci, 2019. 30: 266.

https://www.e-urol-sci.com/article.asp?issn=1879-5226;year=2019;volume=30;issue=6;spage=266;epage=271;aulast=Lee

533.Thorner, D.A., et al. Outcomes of reduction cystoplasty in men with impaired detrusor contractility. Urology, 2014. 83: 882.

https://pubmed.ncbi.nlm.nih.gov/24548706/

534.Gakis, G., et al. Functional detrusor myoplasty for bladder acontractility: long-term results. J Urol, 2011. 185: 593.

https://pubmed.ncbi.nlm.nih.gov/21168866/

535.Malde, S., et al. Female bladder outlet obstruction: Common symptoms masking an uncommon cause. Low Urin Tract Symptoms, 2019. 11: 72.

https://pubmed.ncbi.nlm.nih.gov/28990728/

536.Irwin, D.E., et al. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int, 2011. 108: 1132.

https://pubmed.ncbi.nlm.nih.gov/21231991/

537.Moossdorff-Steinhauser, H., et al. A Survey on Voiding Complaints in Women Presenting at a Pelvic Care Center. Curr Urol, 2019. 13: 31.

https://pubmed.ncbi.nlm.nih.gov/31579228/

538.Kupelian, V., et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med, 2006. 166: 2381.

https://pubmed.ncbi.nlm.nih.gov/17130393/

539.Haylen, B.T., et al. Has the true prevalence of voiding difficulty in urogynecology patients been underestimated? Int Urogynecol J Pelvic Floor Dysfunct, 2007. 18: 53.

https://pubmed.ncbi.nlm.nih.gov/16596458/

540.Hoffman, D.S., et al. Female Bladder Outlet Obstruction. Curr Urol Rep, 2016. 17: 31.

https://pubmed.ncbi.nlm.nih.gov/26902625/

541.Sussman, R.D., et al. Primary Bladder Neck Obstruction. Rev Urol, 2019. 21: 53.

https://pubmed.ncbi.nlm.nih.gov/31768132/

542.Brucker, B.M., et al. Comparison of urodynamic findings in women with anatomical versus functional bladder outlet obstruction. Female Pelvic Med Reconstr Surg, 2013. 19: 46.

https://pubmed.ncbi.nlm.nih.gov/23321659/

543.Nitti, V.W. Primary bladder neck obstruction in men and women. Rev Urol, 2005. 7 Suppl 8: S12.

https://pubmed.ncbi.nlm.nih.gov/16985885/

544.Panicker, J.N., et al. Do we understand voiding dysfunction in women? Current understanding and future perspectives: ICI-RS 2017. Neurourol Urodyn, 2018. 37: S75.

https://pubmed.ncbi.nlm.nih.gov/30133794/

545.Karmakar, D., et al. Current concepts in voiding dysfunction and dysfunctional voiding: A review from a urogynaecologist’s perspective. J Midlife Health, 2014. 5: 104.

https://pubmed.ncbi.nlm.nih.gov/25316994/

546.Panesar, K. Drug-Induced Urinary Incontinence. US Pharm, 2014. 39: 24.

https://www.uspharmacist.com/article/druginduced-urinary-incontinence

547.Groutz, A., et al. Bladder outlet obstruction in women: definition and characteristics. Neurourol Urodyn, 2000. 19: 213.

https://pubmed.ncbi.nlm.nih.gov/10797578/

548.Rosenblum, N., et al. Voiding dysfunction in young, nulliparous women: symptoms and urodynamic findings. Int Urogynecol J Pelvic Floor Dysfunct, 2004. 15: 373.

https://pubmed.ncbi.nlm.nih.gov/15278258/

549.Massey, J.A., et al. Obstructed voiding in the female. Br J Urol, 1988. 61: 36.

https://pubmed.ncbi.nlm.nih.gov/3342298/

550.Gravina, G.L., et al. Urodynamic obstruction in women with stress urinary incontinence--do nonintubated uroflowmetry and symptoms aid diagnosis? J Urol, 2007. 178: 959.

https://pubmed.ncbi.nlm.nih.gov/17632142/

551.Klijer, R., et al. Bladder outlet obstruction in women: difficulties in the diagnosis. Urol Int, 2004. 73: 6.

https://pubmed.ncbi.nlm.nih.gov/15263784/

552.Hsiao, S.M., et al. Videourodynamic Studies of Women with Voiding Dysfunction. Sci Rep, 2017.
7: 6845.

https://pubmed.ncbi.nlm.nih.gov/28754926/

553.Qian, M., et al. Value of Real-Time Shear Wave Elastography Versus Acoustic Radiation Force Impulse Imaging in the Diagnosis of Female Bladder Neck Obstruction. J Ultrasound Med, 2019. 38: 2427.

https://pubmed.ncbi.nlm.nih.gov/30680774/

554.Galica, V., et al. Use of transvaginal ultrasound in females with primary bladder neck obstruction. A preliminary study. Arch Ital Urol Androl, 2015. 87: 158.

https://pubmed.ncbi.nlm.nih.gov/26150036/

555.Osman, N.I., et al. A systematic review of surgical techniques used in the treatment of female urethral stricture. Eur Urol, 2013. 64: 965.

https://pubmed.ncbi.nlm.nih.gov/23937829/

556.Webb, R.J., et al. Electromyographic abnormalities in the urethral and anal sphincters of women with idiopathic retention of urine. Br J Urol, 1992. 70: 22.

https://pubmed.ncbi.nlm.nih.gov/1638369/

557.Fowler, C.J., et al. Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? BMJ, 1988. 297: 1436.

https://pubmed.ncbi.nlm.nih.gov/3147005/

558.Tawadros, C., et al. External urethral sphincter electromyography in asymptomatic women and the influence of the menstrual cycle. BJU Int, 2015. 116: 423.

https://pubmed.ncbi.nlm.nih.gov/25600712/

559.Osman, N.I., et al. Contemporary surgical management of female urethral stricture disease. Curr Opin Urol, 2015. 25: 341.

https://pubmed.ncbi.nlm.nih.gov/26049879/

560.Rademakers, K., et al. Male bladder outlet obstruction: Time to re-evaluate the definition and reconsider our diagnostic pathway? ICI-RS 2015. Neurourol Urodyn, 2017. 36: 894.

https://pubmed.ncbi.nlm.nih.gov/28444709/

561.Meier, K., et al. Female bladder outlet obstruction: an update on diagnosis and management. Curr Opin Urol, 2016. 26: 334.

https://pubmed.ncbi.nlm.nih.gov/27214578/

562.Blaivas, J.G., et al. Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology. Neurourol Urodyn, 2000. 19: 553.

https://pubmed.ncbi.nlm.nih.gov/11002298/

563.Akikwala, T.V., et al. Comparison of diagnostic criteria for female bladder outlet obstruction. J Urol, 2006. 176: 2093.

https://pubmed.ncbi.nlm.nih.gov/17070266/

564.Lemack, G.E., et al. Pressure flow analysis may aid in identifying women with outflow obstruction.
J Urol, 2000. 163: 1823.

https://pubmed.ncbi.nlm.nih.gov/10799191/

565.Solomon, E., et al. Developing and validating a new nomogram for diagnosing bladder outlet obstruction in women. Neurourol Urodyn, 2018. 37: 368.

https://pubmed.ncbi.nlm.nih.gov/28666055/

566.Lindsay, J., et al. Treatment validation of the Solomon-Greenwell nomogram for female bladder outlet obstruction. Neurourol Urodyn, 2020. 39: 1371.

https://pubmed.ncbi.nlm.nih.gov/32249980/

567.Cormier, L., et al. Diagnosis of female bladder outlet obstruction and relevance of the parameter area under the curve of detrusor pressure during voiding: preliminary results. J Urol, 2002. 167: 2083.

https://pubmed.ncbi.nlm.nih.gov/11956445/

568.Deindl, F.M., et al. Dysfunctional voiding in women: which muscles are responsible? Br J Urol, 1998. 82: 814.

https://pubmed.ncbi.nlm.nih.gov/9883217/

569.Romanzi, L.J., et al. The effect of genital prolapse on voiding. J Urol, 1999. 161: 581.

https://pubmed.ncbi.nlm.nih.gov/9915453/

570.Haq, S., et al. Comparison of effectiveness of clean intermittent self catheterization with no catheterization after internal optical urethrotomy for urethral stricture. J Postgraduate Med Inst, 2019. 33: 64.

https://jpmi.org.pk/index.php/jpmi/article/view/2395

571.Jackson, M.J., et al. Intermittent self-dilatation for urethral stricture disease in males. Cochrane Database Syst Rev, 2014: CD010258.

https://pubmed.ncbi.nlm.nih.gov/25523166/

572.Bailey, C., et al. Conservative management as an initial approach for post-operative voiding dysfunction. Eur J Obstet Gynecol Reprod Biol, 2012. 160: 106.

https://pubmed.ncbi.nlm.nih.gov/22000341/

573.Rijal, A., et al. Bladder outflow problems in females. Nepal Med Coll J, 2013. 15: 46.

https://pubmed.ncbi.nlm.nih.gov/24592794/

574.Madjar, S., et al. A remote controlled intraurethral insert for artificial voiding: a new concept for treating women with voiding dysfunction. J Urol, 1999. 161: 895.

https://pubmed.ncbi.nlm.nih.gov/10022709/

575.Madjar, S., et al. Long-term follow-up of the in-flowtrade mark intraurethral insert for the treatment of women with voiding dysfunction. Eur Urol, 2000. 38: 161.

https://pubmed.ncbi.nlm.nih.gov/10895007/

576.Koh, J.S., et al. Comparison of alpha-blocker, extracorporeal magnetic stimulation alone and in combination in the management of female bladder outlet obstruction. Int Urogynecol J, 2011. 22: 849.

https://pubmed.ncbi.nlm.nih.gov/21107813/

577.Sigala, S., et al. Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. Life Sci, 2004. 76: 417.

https://pubmed.ncbi.nlm.nih.gov/15530504/

578.Kim, D.K., et al. Alpha-1 Adrenergic Receptor Blockers for the Treatment of Lower Urinary Tract Symptoms in Women: A Systematic Review and Meta-Analysis. Int Neurourol J, 2019. 23: 56.

https://pubmed.ncbi.nlm.nih.gov/30943695/

579.Boyd, K., et al. α-adrenergic blockers for the treatment of lower-urinary-tract symptoms and dysfunction in women. Ann Pharmacother, 2014. 48: 711.

https://pubmed.ncbi.nlm.nih.gov/24615630/

580.Meyer, L.E., et al. Tamsulosin for voiding dysfunction in women. Int Urol Nephrol, 2012. 44: 1649.

https://pubmed.ncbi.nlm.nih.gov/22983886/

581.Pischedda, A., et al. Use of alpha1-blockers in female functional bladder neck obstruction. Urol Int, 2005. 74: 256.

https://pubmed.ncbi.nlm.nih.gov/15812214/

582.Kessler, T.M., et al. The effect of terazosin on functional bladder outlet obstruction in women: a pilot study. J Urol, 2006. 176: 1487.

https://pubmed.ncbi.nlm.nih.gov/16952666/

583.Athanasopoulos, A., et al. Effect of alfuzosin on female primary bladder neck obstruction. Int Urogynecol J Pelvic Floor Dysfunct, 2009. 20: 217.

https://pubmed.ncbi.nlm.nih.gov/18982236/

584.Lee, Y.S., et al. Efficacy of an Alpha-Blocker for the Treatment of Nonneurogenic Voiding Dysfunction in Women: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Int Neurourol J, 2018. 22: 30.

https://pubmed.ncbi.nlm.nih.gov/29609420/

585.Hajebrahimi, S., et al. Effect of tamsulosin versus prazosin on clinical and urodynamic parameters in women with voiding difficulty: a randomized clinical trial. Int J Gen Med, 2011. 4: 35.

https://pubmed.ncbi.nlm.nih.gov/21403790/

586.Xu, D., et al. Dysfunctional voiding confirmed by transdermal perineal electromyography, and its effective treatment with baclofen in women with lower urinary tract symptoms: a randomized double-blind placebo-controlled crossover trial. BJU Int, 2007. 100: 588.

https://pubmed.ncbi.nlm.nih.gov/17511770/

587.Chen, C.H., et al. Clinical and urodynamic effects of baclofen in women with functional bladder outlet obstruction: Preliminary report. J Obstet Gynaecol Res, 2016. 42: 560.

https://pubmed.ncbi.nlm.nih.gov/27108667/

588.Datta, S.N., et al. Results of double-blind placebo-controlled crossover study of sildenafil citrate (Viagra) in women suffering from obstructed voiding or retention associated with the primary disorder of sphincter relaxation (Fowler’s Syndrome). Eur Urol, 2007. 51: 489.

https://pubmed.ncbi.nlm.nih.gov/16884844/

589.Rosario, D.J., et al. Effects of intravenous thyrotropin-releasing hormone on urethral closure pressure in females with voiding dysfunction. Eur Urol, 1995. 28: 64.

https://pubmed.ncbi.nlm.nih.gov/8521898/

590.Kao, Y.L., et al. The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction. Toxins (Basel), 2019. 11.

https://pubmed.ncbi.nlm.nih.gov/31847090/

591.Jiang, Y.H., et al. OnabotulinumtoxinA Urethral Sphincter Injection as Treatment for Non-neurogenic Voiding Dysfunction - A Randomized, Double-Blind, Placebo-Controlled Study. Sci Rep, 2016.
6: 38905.

https://pubmed.ncbi.nlm.nih.gov/27958325/

592.Pradhan, A.A. Botulinum toxin: An emerging therapy in female bladder outlet obstruction. Indian
J Urol, 2009. 25: 318.

https://pubmed.ncbi.nlm.nih.gov/19881122/

593.Peeters, K., et al. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction. BJU Int, 2014. 113: 789.

https://pubmed.ncbi.nlm.nih.gov/24238278/

594.Fletcher, S.G., et al. Demographic and urodynamic factors associated with persistent OAB after anterior compartment prolapse repair. Neurourol Urodyn, 2010. 29: 1414.

https://pubmed.ncbi.nlm.nih.gov/20623545/

595.Espuña Pons, M., et al. Post-void residual and voiding dysfunction symptoms in women with pelvic organ prolapse before and after vaginal surgery. A multicenter cohort study. Actas Urol Esp, 2020. 45: 57.

https://pubmed.ncbi.nlm.nih.gov/32593638/

596.Togo, M., et al. Lower urinary tract function improves after laparoscopic sacrocolpopexy for elderly patients with pelvic organ prolapse. Low Urin Tract Symptoms, 2020. 12: 260.

https://pubmed.ncbi.nlm.nih.gov/32347664/

597.Fitzgerald, M.P., et al. Postoperative resolution of urinary retention in patients with advanced pelvic organ prolapse. Am J Obstet Gynecol, 2000. 183: 1361.

https://pubmed.ncbi.nlm.nih.gov/11120497/

598.Hirata, H., et al. Does surgical repair of pelvic prolapse improve patients’ quality of life? Eur Urol, 2004. 45: 213.

https://pubmed.ncbi.nlm.nih.gov/14734009/

599.Basu, M., et al. Urethral dilatation: Is there any benefit over cystoscopy and distension? A randomized trial in women with overactive bladder symptoms. Neurourol Urodyn, 2014. 33: 283.

https://pubmed.ncbi.nlm.nih.gov/23636866/

600.Heidari, F., et al. On demand urethral dilatation versus intermittent urethral dilatation: results and complications in women with urethral stricture. Nephrourol Mon, 2014. 6: e15212.

https://pubmed.ncbi.nlm.nih.gov/24783171/

601.Grivas, N., et al. The effectiveness of otis urethrotomy combined with six weeks urethral dilations until 40 Fr in the treatment of bladder outlet obstruction in women: a prospective study. Urol J, 2014. 10: 1063.

https://pubmed.ncbi.nlm.nih.gov/24469651/

602.Yee, C.H., et al. The effect of urethral calibration on female primary bladder outlet obstruction. Int Urogynecol J, 2012. 23: 217.

https://pubmed.ncbi.nlm.nih.gov/21809157/

603.Popat, S., et al. Long-term management of luminal urethral stricture in women. Int Urogynecol J, 2016. 27: 1735.

https://pubmed.ncbi.nlm.nih.gov/27026141/

604.Choudhury, A. Incisional treatment of obstruction of the female bladder neck. Ann R Coll Surg Engl, 1978. 60: 404.

https://pubmed.ncbi.nlm.nih.gov/697298/

605.Zhang, P., et al. Bladder neck incision for female bladder neck obstruction: long-term outcomes. Urology, 2014. 83: 762.

https://pubmed.ncbi.nlm.nih.gov/24680443/

606.Fu, Q., et al. Transurethral incision of the bladder neck using KTP in the treatment of bladder neck obstruction in women. Urol Int, 2009. 82: 61.

https://pubmed.ncbi.nlm.nih.gov/19172099/

607.Shen, W., et al. Controlled transurethral resection and incision of the bladder neck to treat female primary bladder neck obstruction: Description of a novel surgical procedure. Int J Urol, 2016. 23: 491.

https://pubmed.ncbi.nlm.nih.gov/27037830/

608.Jin, X.B., et al. Modified transurethral incision for primary bladder neck obstruction in women: a method to improve voiding function without urinary incontinence. Urology, 2012. 79: 310.

https://pubmed.ncbi.nlm.nih.gov/22310746/

609.Hoag, N., et al. Surgical management of female urethral strictures. Transl Androl Urol, 2017. 6: S76.

https://pubmed.ncbi.nlm.nih.gov/28791225/

610.Nayyar, R., et al. A Novel Anterior Bladder Tube for Traumatic Bladder Neck Contracture in Females: Initial Results. Urology, 2020. 139: 201.

https://pubmed.ncbi.nlm.nih.gov/32061615/

611.Hampson, L.A., et al. Dorsal buccal graft urethroplasty in female urethral stricture disease: a multi-center experience. Transl Androl Urol, 2019. 8: S6.

https://pubmed.ncbi.nlm.nih.gov/31143666/

612.Gomez, R.G., et al. Female urethral reconstruction: dorsal buccal mucosa graft onlay. World J Urol, 2019. 38: 3047.

https://pubmed.ncbi.nlm.nih.gov/31542825/

613.Tao, T.-T., et al. Novel surgical technique for female distal urethral stricture disease: an evaluation of efficacy and safety compared with urethral dilatation. Int J Clin Exp Med 2018. 11: 12002.

http://www.ijcem.com/files/ijcem0080490.pdf

614.Mouracade, P., et al. Transvaginal tape lysis for urinary obstruction after suburethral tape placement. When to do an immediate replacement? Int Urogynecol J Pelvic Floor Dysfunct, 2008. 19: 1271.

https://pubmed.ncbi.nlm.nih.gov/18461268/

615.McCrery, R., et al. Transvaginal urethrolysis for obstruction after antiincontinence surgery. Int Urogynecol J Pelvic Floor Dysfunct, 2007. 18: 627.

https://pubmed.ncbi.nlm.nih.gov/17036167/

616.Giannis, G., et al. Can urethrolysis resolve outlet obstruction related symptoms after Burch colposuspension for stress urinary incontinence? Eur J Obstet Gynecol Reprod Biol, 2015. 195: 103.

https://pubmed.ncbi.nlm.nih.gov/26512435/

617.Leng, W.W., et al. Delayed treatment of bladder outlet obstruction after sling surgery: association with irreversible bladder dysfunction. J Urol, 2004. 172: 1379.

https://pubmed.ncbi.nlm.nih.gov/15371849/

618.Agnew, G., et al. Functional outcomes for surgical revision of synthetic slings performed for voiding dysfunction: a retrospective study. Eur J Obstet Gynecol Reprod Biol, 2012. 163: 113.

https://pubmed.ncbi.nlm.nih.gov/22579029/

619.Van den Broeck, T., et al. The value of surgical release after obstructive anti-incontinence surgery: An aid for clinical decision making. Neurourol Urodyn, 2015. 34: 736.

https://pubmed.ncbi.nlm.nih.gov/25212178/

620.Hashim, H., et al. International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn, 2019. 38: 499.

https://pubmed.ncbi.nlm.nih.gov/30644584/

621.Bosch, J.L., et al. The prevalence and causes of nocturia. J Urol, 2010. 184: 440.

https://pubmed.ncbi.nlm.nih.gov/20620395/

622.Burgio, K.L., et al. Prevalence and correlates of nocturia in community-dwelling older adults. J Am Geriatr Soc, 2010. 58: 861.

https://pubmed.ncbi.nlm.nih.gov/20406317/

623.Fitzgerald, M.P., et al. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol, 2007. 177: 1385.

https://pubmed.ncbi.nlm.nih.gov/17382738/

624.Rahman, S.N., et al. Phenotyping the Association between Nocturia and Hypertension: A Systematic Review and Meta-Analysis. J Urol, 2021. 205: 1577.

https://pubmed.ncbi.nlm.nih.gov/33081593/

625.Pesonen, J.S., et al. The Impact of Nocturia on Mortality: A Systematic Review and Meta-Analysis.
J Urol, 2020. 203: 486.

https://pubmed.ncbi.nlm.nih.gov/31364920/

626.Smith, A.L., et al. Outcomes of pharmacological management of nocturia with non-antidiuretic agents: does statistically significant equal clinically significant? BJU Int, 2011. 107: 1550.

https://pubmed.ncbi.nlm.nih.gov/21518417/

627.Gordon, D.J., et al. Management Strategies for Nocturia. Curr Urol Rep, 2019. 20: 75.

https://pubmed.ncbi.nlm.nih.gov/31707521/

628.Pauwaert, K., et al. Nocturia through the menopausal transition and beyond: a narrative review. Int Urogynecol J, 2021. 32: 1097.

https://pubmed.ncbi.nlm.nih.gov/33439278/

629.Weiss, J.P., et al. Management of Nocturia and Nocturnal Polyuria. Urology, 2019. 133S: 24.

https://pubmed.ncbi.nlm.nih.gov/31586470/

630.Abraham, L., et al. Development and validation of a quality-of-life measure for men with nocturia. Urology, 2004. 63: 481.

https://pubmed.ncbi.nlm.nih.gov/15028442/

631.Holm-Larsen, T., et al. The Nocturia Impact Diary: a self-reported impact measure to complement the voiding diary. Value Health, 2014. 17: 696.

https://pubmed.ncbi.nlm.nih.gov/25236993/

632.Bower, W.F., et al. TANGO - a screening tool to identify comorbidities on the causal pathway of nocturia. BJU Int, 2017. 119: 933.

https://pubmed.ncbi.nlm.nih.gov/28075514/

633.van Kerrebroeck, P., et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn, 2002. 21: 179.

https://pubmed.ncbi.nlm.nih.gov/11857672/

634.Weiss, J.P., et al. Excessive nocturnal urine production is a major contributing factor to the etiology of nocturia. J Urol, 2011. 186: 1358.

https://pubmed.ncbi.nlm.nih.gov/21855948/

635.Denys, M.A., et al. ICI-RS 2015-Is a better understanding of sleep the key in managing nocturia? Neurourol Urodyn, 2018. 37: 2048.

https://pubmed.ncbi.nlm.nih.gov/27653805/

636.Bedretdinova, D., et al. What Is the Most Effective Treatment for Nocturia or Nocturnal Incontinence in Adult Women? Eur Urol Focus, 2020. 7: 453.

https://pubmed.ncbi.nlm.nih.gov/32061540/

637.Johnson, T.M., 2nd, et al. Effects of behavioral and drug therapy on nocturia in older incontinent women. J Am Geriatr Soc, 2005. 53: 846.

https://pubmed.ncbi.nlm.nih.gov/15877562/

638.Aslan, E., et al. Bladder training and Kegel exercises for women with urinary complaints living in a rest home. Gerontology, 2008. 54: 224.

https://pubmed.ncbi.nlm.nih.gov/18483451/

639.Lo, S.K., et al. Additive Effect of Interferential Therapy Over Pelvic Floor Exercise Alone in the Treatment of Female Urinary Stress and Urge Incontinence: A Randomized Controlled Trial. Hong Kong Physiother J, 2003. 21: 37.

https://www.sciencedirect.com/science/article/pii/S1013702509700387

640.Fitzgerald, M.P., et al. Nocturia, nocturnal incontinence prevalence, and response to anticholinergic and behavioral therapy. Int Urogynecol J Pelvic Floor Dysfunct, 2008. 19: 1545.

https://pubmed.ncbi.nlm.nih.gov/18704249/

641.Wu, C., et al. Effects of unsupervised behavioral and pelvic floor muscle training programs on nocturia, urinary urgency, and urinary frequency in postmenopausal women: Secondary analysis of a randomized, two-arm, parallel design, superiority trial (TULIP study). Maturitas, 2021. 146: 42.

https://pubmed.ncbi.nlm.nih.gov/33722363/

642.Wu, X., et al. Electromyographic Biofeedback for Stress Urinary Incontinence or Pelvic Floor Dysfunction in Women: A Systematic Review and Meta-Analysis. Adv Ther, 2021. 38: 4163.

https://pubmed.ncbi.nlm.nih.gov/34176082/

643.Kyoda, Y., et al. Does cognitive behavioral therapy using a self-check sheet improve night-time frequency in patients with nocturia? Results of a multicenter randomized controlled trial. Int J Urol, 2021.28: 444.

https://pubmed.ncbi.nlm.nih.gov/33458939/

644.But, I., et al. Functional magnetic stimulation for mixed urinary incontinence. J Urol, 2005. 173: 1644.

https://pubmed.ncbi.nlm.nih.gov/15821527/

645.Wang, T., et al. The Efficacy of Continuous Positive Airway Pressure Therapy on Nocturia in Patients With Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis. Int Neurourol J, 2015.
19: 178.

https://pubmed.ncbi.nlm.nih.gov/26620900/

646.Hilton, P., et al. The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female. Br
J Urol, 1982. 54: 252.

https://pubmed.ncbi.nlm.nih.gov/7049302/

647.Lose, G., et al. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women. Am J Obstet Gynecol, 2003. 189: 1106.

https://pubmed.ncbi.nlm.nih.gov/14586363/

648.Yamaguchi, O., et al. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial. BJU Int, 2013. 111: 474.

https://pubmed.ncbi.nlm.nih.gov/23046147/

649.Rovner, E.S., et al. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study. Low Urin Tract Symptoms, 2018. 10: 221.

https://pubmed.ncbi.nlm.nih.gov/28560762/

650.Rembratt, A., et al. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia. Neurourol Urodyn, 2006. 25: 105.

https://pubmed.ncbi.nlm.nih.gov/16304673/

651.Yuan, Z., et al. Comparison of Tolterodine with Estazolam versus Tolterodine alone for the treatment of women with overactive Bladder Syndrome and Nocturia: A non-randomized prospective comparative study. Pakistan J Med Sci Online, 2011. 27: 763.

https://www.researchgate.net/publication/290027958

652.Suzuki, T.A.-O., et al. Effect of oxybutynin patch versus mirabegron on nocturia-related quality of life in female overactive bladder patients: A multicenter randomized trial. Int J Urol, 2021. 28: 944.

https://pubmed.ncbi.nlm.nih.gov/34053119/

653.Lose, G., et al. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. BJOG, 2000. 107: 1029.

https://pubmed.ncbi.nlm.nih.gov/10955437/

654.Reynard, J.M., et al. A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol, 1998. 81: 215.

https://pubmed.ncbi.nlm.nih.gov/9488061/

655.Cameron, A.P. Systematic review of lower urinary tract symptoms occurring with pelvic organ prolapse. Arab J Urol, 2019. 17: 23.

https://pubmed.ncbi.nlm.nih.gov/33110659/

656.Wu, J.M., et al. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol, 2014. 123: 1201.

https://pubmed.ncbi.nlm.nih.gov/24807341/

657.Vergeldt, T.F., et al. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J, 2015. 26: 1559.

https://pubmed.ncbi.nlm.nih.gov/25966804/

658.DeLancey, J.O. What’s new in the functional anatomy of pelvic organ prolapse? Curr Opin Obstet Gynecol, 2016. 28: 420.

https://pubmed.ncbi.nlm.nih.gov/27517338/

659.Chen, A., et al. Management of Postoperative Lower Urinary Tract Symptoms (LUTS) After Pelvic Organ Prolapse (POP) Repair. Curr Urol Rep, 2018. 19: 74.

https://pubmed.ncbi.nlm.nih.gov/30043287/

660.Bump, R.C., et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol, 1996. 175: 10.

https://pubmed.ncbi.nlm.nih.gov/8694033/

661.Theofrastous, J.P., et al. The clinical evaluation of pelvic floor dysfunction. Obstet Gynecol Clin North Am, 1998. 25: 783.

https://pubmed.ncbi.nlm.nih.gov/9921557/

662.Ellerkmann, R.M., et al. Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol, 2001. 185: 1332.

https://pubmed.ncbi.nlm.nih.gov/11744905/

663.Grob, A.T.M., et al. Underestimation of pelvic organ prolapse in the supine straining position, based on magnetic resonance imaging findings. Int Urogynecol J, 2019. 30: 1939.

https://pubmed.ncbi.nlm.nih.gov/30656361/

664.Espuña-Pons, M., et al. Cough stress tests to diagnose stress urinary incontinence in women with pelvic organ prolapse with indication for surgical treatment. Neurourol Urodyn, 2020. 39: 819.

https://pubmed.ncbi.nlm.nih.gov/32040873/

665.Visco, A.G., et al. The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial. Int Urogynecol J Pelvic Floor Dysfunct, 2008. 19: 607.

https://pubmed.ncbi.nlm.nih.gov/18185903/

666.Wei, J.T., et al. A midurethral sling to reduce incontinence after vaginal prolapse repair. N Engl
J Med, 2012. 366: 2358.

https://pubmed.ncbi.nlm.nih.gov/22716974/

667.van der Ploeg, J.M., et al. The predictive value of demonstrable stress incontinence during basic office evaluation and urodynamics in women without symptomatic urinary incontinence undergoing vaginal prolapse surgery. Neurourol Urodyn, 2018. 37: 1011.

https://pubmed.ncbi.nlm.nih.gov/28834564/

668.Jelovsek, J.E., et al. A model for predicting the risk of de novo stress urinary incontinence in women undergoing pelvic organ prolapse surgery. Obstet Gynecol, 2014. 123: 279.

https://pubmed.ncbi.nlm.nih.gov/24402598/

669.Lo, T.S., et al. Predictors for detrusor overactivity following extensive vaginal pelvic reconstructive surgery. Neurourol Urodyn, 2018. 37: 192.

https://pubmed.ncbi.nlm.nih.gov/28370456/

670.Lo, T.S., et al. Clinical outcomes of detrusor underactivity in female with advanced pelvic organ prolapse following vaginal pelvic reconstructive surgery. Neurourol Urodyn, 2018. 37: 2242.

https://pubmed.ncbi.nlm.nih.gov/29664135/

671.Frawley, H.C., et al. Physiotherapy as an adjunct to prolapse surgery: an assessor-blinded randomized controlled trial. Neurourol Urodyn, 2010. 29: 719.

https://pubmed.ncbi.nlm.nih.gov/19816918/

672.Braekken, I.H., et al. Can pelvic floor muscle training reverse pelvic organ prolapse and reduce prolapse symptoms? An assessor-blinded, randomized, controlled trial. Am J Obstet Gynecol, 2010. 203: 170 e1.

https://pubmed.ncbi.nlm.nih.gov/20435294/

673.Cheung, R.Y., et al. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial. Obstet Gynecol, 2016. 128: 73.

https://pubmed.ncbi.nlm.nih.gov/27275798/

674.Due, U., et al. Lifestyle advice with or without pelvic floor muscle training for pelvic organ prolapse: a randomized controlled trial. Int Urogynecol J, 2016. 27: 555.

https://pubmed.ncbi.nlm.nih.gov/26439114/

675.Due, U., et al. The 12-month effects of structured lifestyle advice and pelvic floor muscle training for pelvic organ prolapse. Acta Obstet Gynecol Scand, 2016. 95: 811.

https://pubmed.ncbi.nlm.nih.gov/26910261/

676.Hagen, S., et al. Individualised pelvic floor muscle training in women with pelvic organ prolapse (POPPY): a multicentre randomised controlled trial. Lancet, 2014. 383: 796.

https://pubmed.ncbi.nlm.nih.gov/24290404/

677.Panman, C.M., et al. Effectiveness and cost-effectiveness of pessary treatment compared with pelvic floor muscle training in older women with pelvic organ prolapse: 2-year follow-up of a randomized controlled trial in primary care. Menopause, 2016. 23: 1307.

https://pubmed.ncbi.nlm.nih.gov/27504918/

678.Duarte, T.B., et al. Perioperative pelvic floor muscle training did not improve outcomes in women undergoing pelvic organ prolapse surgery: a randomised trial. J Physiother, 2020. 66: 27.

https://pubmed.ncbi.nlm.nih.gov/31843420/

679.Pauls, R.N., et al. Pelvic floor physical therapy: impact on quality of life 6 months after vaginal reconstructive surgery. Female Pelvic Med Reconstr Surg, 2014. 20: 334.

https://pubmed.ncbi.nlm.nih.gov/25185628/

680.Barber, M.D., et al. Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. JAMA, 2014. 311: 1023.

https://pubmed.ncbi.nlm.nih.gov/24618964/

681.Weidner, A.C., et al. Perioperative Behavioral Therapy and Pelvic Muscle Strengthening Do Not Enhance Quality of Life After Pelvic Surgery: Secondary Report of a Randomized Controlled Trial. Phys Ther, 2017. 97: 1075.

https://pubmed.ncbi.nlm.nih.gov/29077924/

682.Hagen, S., et al. Pelvic floor muscle training for secondary prevention of pelvic organ prolapse (PREVPROL): a multicentre randomised controlled trial. Lancet, 2017. 389: 393.

https://pubmed.ncbi.nlm.nih.gov/28010994/

683.Panman, C., et al. Two-year effects and cost-effectiveness of pelvic floor muscle training in mild pelvic organ prolapse: a randomised controlled trial in primary care. BJOG, 2017. 124: 511.

https://pubmed.ncbi.nlm.nih.gov/26996291/

684.van der Vaart, L.A.-O., et al. Pessary or surgery for a symptomatic pelvic organ prolapse: the PEOPLE study, a multicentre prospective cohort study. BJOG, 2021.

https://pubmed.ncbi.nlm.nih.gov/34559932/

685.de Boer, T.A., et al. Pelvic organ prolapse and overactive bladder. Neurourol Urodyn, 2010. 29: 30.

https://pubmed.ncbi.nlm.nih.gov/20025017/

686.de Boer, T.A., et al. Predictive factors for overactive bladder symptoms after pelvic organ prolapse surgery. Int Urogynecol J, 2010. 21: 1143.

https://pubmed.ncbi.nlm.nih.gov/20419366/

687.Kim, M.S., et al. The association of pelvic organ prolapse severity and improvement in overactive bladder symptoms after surgery for pelvic organ prolapse. Obstet Gynecol Sci, 2016. 59: 214.

https://pubmed.ncbi.nlm.nih.gov/27200312/

688.Costantini, E., et al. Urgency, detrusor overactivity and posterior vault prolapse in women who underwent pelvic organ prolapse repair. Urol Int, 2013. 90: 168.

https://pubmed.ncbi.nlm.nih.gov/23327990/

689.van der Ploeg, J.M., et al. Prolapse surgery with or without incontinence procedure: a systematic review and meta-analysis. BJOG. 2018. 125: 289.

https://pubmed.ncbi.nlm.nih.gov/28941138/

690.Baessler, K., et al. Surgery for women with pelvic organ prolapse with or without stress urinary incontinence. Cochrane Database Syst Rev, 2018. 8: CD013108.

https://pubmed.ncbi.nlm.nih.gov/30121956/

691.Borstad, E., et al. Surgical strategies for women with pelvic organ prolapse and urinary stress incontinence. Int Urogynecol J, 2010. 21: 179.

https://pubmed.ncbi.nlm.nih.gov/19940978/

692.van der Ploeg, J.M., et al. Transvaginal prolapse repair with or without the addition of a midurethral sling in women with genital prolapse and stress urinary incontinence: a randomised trial. BJOG, 2015. 122: 1022.

https://pubmed.ncbi.nlm.nih.gov/25754458/

693.Costantini, E., et al. Burch colposuspension does not provide any additional benefit to pelvic organ prolapse repair in patients with urinary incontinence: a randomized surgical trial. J Urol, 2008. 180: 1007.

https://pubmed.ncbi.nlm.nih.gov/18639302/

694.Costantini, E., et al. Pelvic Organ Prolapse Repair with and without Concomitant Burch Colposuspension in Incontinent Women: A Randomised Controlled Trial with at Least 5-Year Followup. Obstet Gynecol Int, 2012. 2012: 967923.

https://pubmed.ncbi.nlm.nih.gov/22028719/

695.Trabuco, E.C., et al. Treatment success of burch and midurethral sling 2 years following combined procedure with sacrocolpopexy. Int Urogynecol J, 2016. 27: S46.

https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01267274/full

696.Costantini, E., et al. Must colposuspension be associated with sacropexy to prevent postoperative urinary incontinence? Eur Urol, 2007. 51: 788.

https://pubmed.ncbi.nlm.nih.gov/17011699/

697.Brubaker, L., et al. Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med, 2006. 354: 1557.

https://pubmed.ncbi.nlm.nih.gov/16611949/

698.Meschia, M., et al. A randomized comparison of tension-free vaginal tape and endopelvic fascia plication in women with genital prolapse and occult stress urinary incontinence. Am J Obstet Gynecol, 2004. 190: 609.

https://pubmed.ncbi.nlm.nih.gov/15041988/

699.Fuentes, A.E. A prospective randomised controlled trial comparing vaginal prolapse repair with and without tensionfree vaginal tape transobturator tape (TVTO) in women with severe genital prolapse and occult stress incontinence: long term follow up. Int Urogynecol J, 2011. 22: Abstract 059:S60.

https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01005287/full

700.Schierlitz, L., et al. Pelvic organ prolapse surgery with and without tension-free vaginal tape in women with occult or asymptomatic urodynamic stress incontinence: a randomised controlled trial. Int Urogynecol J, 2014. 25: 33.

https://pubmed.ncbi.nlm.nih.gov/23812579/

701.van der Ploeg, J.M., et al. Vaginal prolapse repair with or without a midurethral sling in women with genital prolapse and occult stress urinary incontinence: a randomized trial. Int Urogynecol J, 2016. 27: 1029.

https://pubmed.ncbi.nlm.nih.gov/26740197/

702.De Ridder, D. et al. Fistula (Committee 18), In: Incontinence, P. Abrams, Cardozo, L, Wagg, A, Wein, A, Editor. 2017, ICI-ICS International Continence Society: Bristol UK.

https://www.ics.org/publications/ici_6/Incontinence_6th_Edition_2017_eBook_v2.pdf

703.de Bernis, L. Obstetric fistula: Guiding principles for clinical management and programme development, a new WHO guideline. Int J Gynecol Obstet, 2007. 99: S117.

https://pubmed.ncbi.nlm.nih.gov/17880979/

704.Mselle, L.T., et al. Perceived Health System Causes of Obstetric Fistula from Accounts of Affected Women in Rural Tanzania: A Qualitative Study. Afr J Reprod Health, 2015. 19: 124.

https://pubmed.ncbi.nlm.nih.gov/26103702/

705.Mwini-Nyaledzigbor, P.P., et al. Lived experiences of Ghanaian women with obstetric fistula. Health Care Women Int, 2013. 34: 440.

https://pubmed.ncbi.nlm.nih.gov/23641897/

706.Jokhio, A.H., et al. Prevalence of obstetric fistula: a population-based study in rural Pakistan. BJOG, 2014. 121: 1039.

https://pubmed.ncbi.nlm.nih.gov/24684695/

707.Farid, F.N., et al. Psychosocial experiences of women with vesicovaginal fistula: a qualitative approach. J Coll Physicians Surg Pak, 2013. 23: 828.

https://pubmed.ncbi.nlm.nih.gov/24169399/

708.Imoto, A., et al. Health-related quality of life among women in rural Bangladesh after surgical repair of obstetric fistula. Int J Gynaecol Obstet, 2015. 130: 79.

https://pubmed.ncbi.nlm.nih.gov/25935472/

709.Tancer, M.L. Observations on prevention and management of vesicovaginal fistula after total hysterectomy. Surg Gynecol Obstet, 1992. 175: 501.

https://pubmed.ncbi.nlm.nih.gov/1448730/

710.Hadzi-Djokic, J., et al. Vesico-vaginal fistula: report of 220 cases. Int Urol Nephrol, 2009. 41: 299.

https://pubmed.ncbi.nlm.nih.gov/18810652/

711.Forsgren, C., et al. Risk of pelvic organ fistula in patients undergoing hysterectomy. Curr Opin Obstet Gynecol, 2010. 22: 404.

https://pubmed.ncbi.nlm.nih.gov/20739885/

712.Likic, I.S., et al. Analysis of urologic complications after radical hysterectomy. Am J Obstet Gynecol, 2008. 199: 644 e1.

https://pubmed.ncbi.nlm.nih.gov/18722569/

713.Hilton, P., et al. The risk of vesicovaginal and urethrovaginal fistula after hysterectomy performed in the English National Health Service--a retrospective cohort study examining patterns of care between 2000 and 2008. BJOG, 2012. 119: 1447.

https://pubmed.ncbi.nlm.nih.gov/22901248/

714.Liedl, B., et al. Outcomes of a bladder preservation technique in female patients undergoing pelvic exenteration surgery for advanced gynaecological tumours. Int Urogynecol J, 2014. 25: 953.

https://pubmed.ncbi.nlm.nih.gov/24633066/

715.Kucera, H., et al. [Complications of postoperative radiotherapy in uterine cancer]. Geburtshilfe Frauenheilkd, 1984. 44: 498.

https://pubmed.ncbi.nlm.nih.gov/6566638/

716.Biewenga, P., et al. Can we predict vesicovaginal or rectovaginal fistula formation in patients with stage IVA cervical cancer? Int J Gynecol Cancer, 2010. 20: 471.

https://pubmed.ncbi.nlm.nih.gov/20375815/

717.Adaji, S.E., et al. Vaginally inserted herbs causing vesico-vaginal fistula and vaginal stenosis. Int Urogynecol J, 2013. 24: 1057.

https://pubmed.ncbi.nlm.nih.gov/22797463/

718.Donaldson, J.F., et al. Obstructive uropathy and vesicovaginal fistula secondary to a retained sex toy in the vagina. J Sex Med, 2014. 11: 2595.

https://pubmed.ncbi.nlm.nih.gov/24919434/

719.Penrose, K.J., et al. Delayed vesicovaginal fistula after ring pessary usage. Int Urogynecol J, 2014. 25: 291.

https://pubmed.ncbi.nlm.nih.gov/23801483/

720.Huang, L.K., et al. Evaluation of the extent of ketamine-induced uropathy: the role of CT urography. Postgrad Med J, 2014. 90: 185.

https://pubmed.ncbi.nlm.nih.gov/24443558/

721.Browning, A. Risk factors for developing residual urinary incontinence after obstetric fistula repair. BJOG, 2006. 113: 482.

https://pubmed.ncbi.nlm.nih.gov/16489933/

722.Goh, J.T. A new classification for female genital tract fistula. Aust N Z J Obstet Gynaecol, 2004.
44: 502.

https://pubmed.ncbi.nlm.nih.gov/15598284/

723.Goh, J.T., et al. Predicting the risk of failure of closure of obstetric fistula and residual urinary incontinence using a classification system. Int Urogynecol J Pelvic Floor Dysfunct, 2008. 19: 1659.

https://pubmed.ncbi.nlm.nih.gov/18690403/

724.Beardmore-Gray, A., et al. Does the Goh classification predict the outcome of vesico-vaginal fistula repair in the developed world? Int Urogynecol J, 2017. 28: 937.

https://pubmed.ncbi.nlm.nih.gov/27822888/

725.Ostrzenski, A., et al. Bladder injury during laparoscopic surgery. Obstet Gynecol Surv, 1998. 53: 175.

https://pubmed.ncbi.nlm.nih.gov/9513988/

726.Narayanan, P., et al. Fistulas in malignant gynecologic disease: etiology, imaging, and management. Radiographics, 2009. 29: 1073.

https://pubmed.ncbi.nlm.nih.gov/19605657/

727.Latzko, W. Postoperative vesicovaginal fistulas. Am J Surg, 1942. 58: 211.

https://www.sciencedirect.com/science/article/abs/pii/S0002961042900096

728.Rajaian, S., et al. Vesicovaginal fistula: Review and recent trends. Indian J Urol, 2019. 35: 250.

https://pubmed.ncbi.nlm.nih.gov/31619862/

729.Yokoyama, M., et al. Successful management of vesicouterine fistula by luteinizing hormone-releasing hormone analog. Int J Urol, 2006. 13: 457.

https://pubmed.ncbi.nlm.nih.gov/16734874/

730.Goh, J.T., et al. Oestrogen therapy in the management of vesicovaginal fistula. Aust N Z J Obstet Gynaecol, 2001. 41: 333.

https://pubmed.ncbi.nlm.nih.gov/11592553/

731.Hemal, A.K., et al. Youssef’s syndrome: an appraisal of hormonal treatment. Urol Int, 1994. 52: 55.

https://pubmed.ncbi.nlm.nih.gov/8140684/

732.Tarhan, F., et al. Minimal invasive treatment of vesicouterine fistula: a case report. Int Urol Nephrol, 2007. 39: 791.

https://pubmed.ncbi.nlm.nih.gov/17006733/

733.Kumar, A., et al. Management of vesico-uterine fistulae: a report of six cases. Int J Gynaecol Obstet, 1988. 26: 453.

https://pubmed.ncbi.nlm.nih.gov/2900177/

734.Rubino, S.M. Vesico-uterine fistula treated by amenorrhoea induced with contraceptive steroids. Two case reports. Br J Obstet Gynaecol, 1980. 87: 343.

https://pubmed.ncbi.nlm.nih.gov/7426505/

735.Jó�wik, M., et al. Spontaneous closure of vesicouterine fistula. Account for effective hormonal treatment. Urol Int, 1999. 62: 183.

https://pubmed.ncbi.nlm.nih.gov/10529673/

736.Safan, A., et al. Fibrin glue versus martius flap interpositioning in the repair of complicated obstetric vesicovaginal fistula. A prospective multi-institution randomized trial. Neurourol Urodyn, 2009. 28: 438.

https://pubmed.ncbi.nlm.nih.gov/19475577/

737.Garrido-Ruiz, M.C., et al. Vulvar pseudoverrucous papules and nodules secondary to a urethral--vaginal fistula. Am J Dermatopathol, 2011. 33: 410.

https://pubmed.ncbi.nlm.nih.gov/21285858/

738.Onuora, V.C., et al. Iatrogenic urogenital fistulae. Br J Urol, 1993. 71: 176.

https://pubmed.ncbi.nlm.nih.gov/8461950/

739.Tsai, M.S., et al. Surgery is justified in patients with bowel obstruction due to radiation therapy.
J Gastrointest Surg, 2006. 10: 575.

https://pubmed.ncbi.nlm.nih.gov/16627224/

740.Shackley, D.C., et al. The staged management of complex entero-urinary fistulae. BJU Int, 2000.
86: 624.

https://pubmed.ncbi.nlm.nih.gov/11069366/

741.Eyre, R.C., et al. Management of urinary and bowel complications after ileal conduit diversion.
J Urol, 1982. 128: 1177.

https://pubmed.ncbi.nlm.nih.gov/7154168/

742.Waaldijk, K., et al. The obstetric fistula and peroneal nerve injury: An analysis of 947 consecutive patients. Int Urogynecol J, 1994. 5: 12.

https://link.springer.com/article/10.1007/BF00451704

743.Hilton, P. Vesico-vaginal fistulas in developing countries. Int J Gynaecol Obstet, 2003. 82: 285.

https://pubmed.ncbi.nlm.nih.gov/14499975/

744.Niël-Weise, B.S., et al. Antibiotic policies for short-term catheter bladder drainage in adults. Cochrane Database Syst Rev, 2005: CD005428.

https://pubmed.ncbi.nlm.nih.gov/16034973/

745.Wall, L.L. Dr. George Hayward (1791-1863): a forgotten pioneer of reconstructive pelvic surgery. Int Urogynecol J Pelvic Floor Dysfunct, 2005. 16: 330.

https://pubmed.ncbi.nlm.nih.gov/15976986/

746.Hilton, P., et al. Epidemiological and surgical aspects of urogenital fistulae: a review of 25 years’ experience in southeast Nigeria. Int Urogynecol J Pelvic Floor Dysfunct, 1998. 9: 189.

https://pubmed.ncbi.nlm.nih.gov/9795822/

747.Shaker, H., et al. Obstetric vesico-vaginal fistula repair: should we trim the fistula edges? A randomized prospective study. Neurourol Urodyn, 2011. 30: 302.

https://pubmed.ncbi.nlm.nih.gov/21308748/

748.Krause, S., et al. Surgery for urologic complications following radiotherapy for gynecologic cancer. Scand J Urol Nephrol, 1987. 21: 115.

https://pubmed.ncbi.nlm.nih.gov/3616502/

749.Langkilde, N.C., et al. Surgical repair of vesicovaginal fistulae--a ten-year retrospective study. Scand J Urol Nephrol, 1999. 33: 100.

https://pubmed.ncbi.nlm.nih.gov/10360449/

750.Lumen, N., et al. Review of the current management of lower urinary tract injuries by the EAU Trauma Guidelines Panel. Eur Urol, 2015. 67: 925.

https://pubmed.ncbi.nlm.nih.gov/25576009/

751.Brandes, S., et al. Diagnosis and management of ureteric injury: an evidence-based analysis. BJU Int, 2004. 94: 277.

https://pubmed.ncbi.nlm.nih.gov/15291852/

752.Morton, H.C., et al. Urethral injury associated with minimally invasive mid-urethral sling procedures for the treatment of stress urinary incontinence: a case series and systematic literature search. BJOG, 2009. 116: 1120.

https://pubmed.ncbi.nlm.nih.gov/19438488/

753.Narang, V., et al. Ureteroscopy: savior to the gynecologist? Ureteroscopic management of post laparoscopic-assisted vaginal hysterectomy ureterovaginal fistulas. J Minim Invasive Gynecol, 2007. 14: 345.

https://pubmed.ncbi.nlm.nih.gov/17478367/

754.Poletajew, S., et al. Kidney removal: the past, presence, and perspectives: a historical review. Urol J, 2010. 7: 215.

https://pubmed.ncbi.nlm.nih.gov/21170847/

755.Matz, M. [Prognosis-oriented diagnosis, treatment protocol and after care in uretero-vaginal fistula following gynecological surgery from the urological viewpoint]. Zentralbl Gynakol, 1990. 112: 1345.

https://pubmed.ncbi.nlm.nih.gov/2278219/

756.Benchekroun, A., et al. [Uretero-vaginal fistulas. 45 cases]. Ann Urol (Paris), 1998. 32: 295.

https://pubmed.ncbi.nlm.nih.gov/9827201/

757.el Ouakdi, M., et al. [Uretero-vaginal fistula. Apropos of 30 cases]. J Gynecol Obstet Biol Reprod (Paris), 1989. 18: 891.

https://pubmed.ncbi.nlm.nih.gov/2614029/

758.Murphy, D.M., et al. Ureterovaginal fistula: a report of 12 cases and review of the literature. J Urol, 1982. 128: 924.

https://pubmed.ncbi.nlm.nih.gov/7176053/

759.Abou-El-Ghar, M.E., et al. Radiological diagnosis of vesicouterine fistula: role of magnetic resonance imaging. J Magn Reson Imaging, 2012. 36: 438.

https://pubmed.ncbi.nlm.nih.gov/22535687/

760.Quiroz, L.H., et al. Three-dimensional ultrasound imaging for diagnosis of urethrovaginal fistula. Int Urogynecol J, 2010. 21: 1031.

https://pubmed.ncbi.nlm.nih.gov/20069418/

761.Goodwin, W.E., et al. Vesicovaginal and ureterovaginal fistulas: a summary of 25 years of experience. J Urol, 1980. 123: 370.

https://pubmed.ncbi.nlm.nih.gov/7359641/

762.Pushkar, D.Y., et al. Management of urethrovaginal fistulas. Eur Urol, 2006. 50: 1000.

https://pubmed.ncbi.nlm.nih.gov/16945476/

763.Pushkar, D. Editorial comment on: Transpubic access using pedicle tubularized labial urethroplasty for the treatment of female urethral strictures associated with urethrovaginal fistulas secondary to pelvic fracture. Eur Urol, 2009. 56: 200.

https://pubmed.ncbi.nlm.nih.gov/18468776/

764.Xu, Y.M., et al. Transpubic access using pedicle tubularized labial urethroplasty for the treatment of female urethral strictures associated with urethrovaginal fistulas secondary to pelvic fracture. Eur Urol, 2009. 56: 193.

https://pubmed.ncbi.nlm.nih.gov/18468778/

765.Huang, C.R., et al. The management of old urethral injury in young girls: analysis of 44 cases.
J Pediatr Surg, 2003. 38: 1329.

https://pubmed.ncbi.nlm.nih.gov/14523814/

766.Candiani, P., et al. Repair of a recurrent urethrovaginal fistula with an island bulbocavernous musculocutaneous flap. Plast Reconstr Surg, 1993. 92: 1393.

https://pubmed.ncbi.nlm.nih.gov/8248420/

767.McKinney, D.E. Use of full thickness patch graft in urethrovaginal fistula. J Urol, 1979. 122: 416.

https://pubmed.ncbi.nlm.nih.gov/381691/

768.Browning, A. Lack of value of the Martius fibrofatty graft in obstetric fistula repair. Int J Gynaecol Obstet, 2006. 93: 33.

https://pubmed.ncbi.nlm.nih.gov/16530766/

769.Baskin, D., et al. Martius repair in urethrovaginal defects. J Pediatr Surg, 2005. 40: 1489.

https://pubmed.ncbi.nlm.nih.gov/16150356/

770.Atan, A., et al. Treatment of refractory urethrovaginal fistula using rectus abdominis muscle flap in a six-year-old girl. Urology, 2007. 69: 384 e11.

https://pubmed.ncbi.nlm.nih.gov/17320687/

771.Bruce, R.G., et al. Use of rectus abdominis muscle flap for the treatment of complex and refractory urethrovaginal fistulas. J Urol, 2000. 163: 1212.

https://pubmed.ncbi.nlm.nih.gov/10737499/

772.Koraitim, M. A new retropubic retrourethral approach for large vesico-urethrovaginal fistulas. J Urol, 1985. 134: 1122.

https://pubmed.ncbi.nlm.nih.gov/4057401/

773.Rovner, E.S. Urethral diverticula: a review and an update. Neurourol Urodyn, 2007. 26: 972.

https://pubmed.ncbi.nlm.nih.gov/17654566/

774.Crescenze, I.M., et al. Female Urethral Diverticulum: Current Diagnosis and Management. Curr Urol Rep, 2015. 16: 71.

https://pubmed.ncbi.nlm.nih.gov/26267225/

775.El-Nashar, S.A., et al. Incidence of female urethral diverticulum: a population-based analysis and literature review. Int Urogynecol J, 2014. 25: 73.

https://pubmed.ncbi.nlm.nih.gov/23857063/

776.Adelowo, A., et al. The role of preoperative urodynamics in urogynecologic procedures. J Minim Invasive Gynecol, 2014. 21: 217.

https://pubmed.ncbi.nlm.nih.gov/24144925/

777.Reeves, F.A., et al. Management of symptomatic urethral diverticula in women: a single-centre experience. Eur Urol, 2014. 66: 164.

https://pubmed.ncbi.nlm.nih.gov/24636677/

778.Athanasopoulos, A., et al. Urethral diverticulum: a new complication associated with tension-free vaginal tape. Urol Int, 2008. 81: 480.

https://pubmed.ncbi.nlm.nih.gov/19077415/

779.Hammad, F.T. TVT can also cause urethral diverticulum. Int Urogynecol J Pelvic Floor Dysfunct, 2007. 18: 467.

https://pubmed.ncbi.nlm.nih.gov/16821000/

780.Mahdy, A., et al. Urethral diverticulum after tension-free vaginal tape procedure: case report. Urology, 2008. 72: 461 e5.

https://pubmed.ncbi.nlm.nih.gov/18355901/

781.Han, D.H., et al. Outcomes of surgery of female urethral diverticula classified using magnetic resonance imaging. Eur Urol, 2007. 51: 1664.

https://pubmed.ncbi.nlm.nih.gov/17335961/

782.Leach, G.E., et al. L N S C3: a proposed classification system for female urethral diverticula. Neurourol Urodyn, 1993. 12: 523.

https://pubmed.ncbi.nlm.nih.gov/8312937/

783.Cameron, A.P. Urethral diverticulum in the female: a meta-analysis of modern series. Minerva Ginecol, 2016. 68: 186.

https://pubmed.ncbi.nlm.nih.gov/26545036/

784.Blander, D.S., et al. Endoluminal magnetic resonance imaging in the evaluation of urethral diverticula in women. Urology, 2001. 57: 660.

https://pubmed.ncbi.nlm.nih.gov/11306374/

785.Pathi, S.D., et al. Utility of clinical parameters, cystourethroscopy, and magnetic resonance imaging in the preoperative diagnosis of urethral diverticula. Int Urogynecol J, 2013. 24: 319.

https://pubmed.ncbi.nlm.nih.gov/22707007/

786.Dwarkasing, R.S., et al. MRI evaluation of urethral diverticula and differential diagnosis in symptomatic women. AJR Am J Roentgenol, 2011. 197: 676.

https://pubmed.ncbi.nlm.nih.gov/21862811/

787.Chung, D.E., et al. Urethral diverticula in women: discrepancies between magnetic resonance imaging and surgical findings. J Urol, 2010. 183: 2265.

https://pubmed.ncbi.nlm.nih.gov/20400161/

788.Blander, D.S., et al. Images in clinical urology. Magnetic resonance imaging of a “saddle bag” urethral diverticulum. Urology, 1999. 53: 818.

https://pubmed.ncbi.nlm.nih.gov/10197865/

789.Khati, N.J., et al. MR imaging diagnosis of a urethral diverticulum. Radiographics, 1998. 18: 517.

https://pubmed.ncbi.nlm.nih.gov/9536494/

790.Rovner, E.S., et al. Diagnosis and reconstruction of the dorsal or circumferential urethral diverticulum. J Urol, 2003. 170: 82.

https://pubmed.ncbi.nlm.nih.gov/12796650/

791.Chou, C.P., et al. Imaging of female urethral diverticulum: an update. Radiographics, 2008. 28: 1917.

https://pubmed.ncbi.nlm.nih.gov/19001648/

792.Gugliotta, G., et al. Use of trans-labial ultrasound in the diagnosis of female urethral diverticula: A diagnostic option to be strongly considered. J Obstet Gynaecol Res, 2015. 41: 1108.

https://pubmed.ncbi.nlm.nih.gov/25772163/

793.Baradaran, N., et al. Female Urethral Diverticula in the Contemporary Era: Is the Classic Triad of the “3Ds” Still Relevant? Urology, 2016. 94: 53.

https://pubmed.ncbi.nlm.nih.gov/27079128/

794.Stav, K., et al. Urinary symptoms before and after female urethral diverticulectomy--can we predict de novo stress urinary incontinence? J Urol, 2008. 180: 2088.

https://pubmed.ncbi.nlm.nih.gov/18804229/

795.Ockrim, J.L., et al. A tertiary experience of urethral diverticulectomy: diagnosis, imaging and surgical outcomes. BJU Int, 2009. 103: 1550.

https://pubmed.ncbi.nlm.nih.gov/19191783/

796.Bhatia, N.N., et al. Urethral pressure profiles of women with urethral diverticula. Obstet Gynecol, 1981. 58: 375.

https://pubmed.ncbi.nlm.nih.gov/7196559/

797.Reid, R.E., et al. Role of urodynamics in management of urethral diverticulum in females. Urology, 1986. 28: 342.

https://pubmed.ncbi.nlm.nih.gov/3094219/

798.Summitt, R.L., Jr., et al. Urethral diverticula: evaluation by urethral pressure profilometry, cystourethroscopy, and the voiding cystourethrogram. Obstet Gynecol, 1992. 80: 695.

https://pubmed.ncbi.nlm.nih.gov/1407897/

799.Bass, J.S., et al. Surgical treatment of concomitant urethral diverticulum and stress incontinence. Urol Clin North Am, 1991. 18: 365.

https://pubmed.ncbi.nlm.nih.gov/1902010/

800.Ganabathi, K., et al. Experience with the management of urethral diverticulum in 63 women. J Urol, 1994. 152: 1445.

https://pubmed.ncbi.nlm.nih.gov/7933181/

801.Wagner, U., et al. [Significance of the urethral pressure profile in the diagnosis of urethral diverticulum]. Geburtshilfe Frauenheilkd, 1986. 46: 456.

https://pubmed.ncbi.nlm.nih.gov/3093308/

802.Thomas, A.A., et al. Urethral diverticula in 90 female patients: a study with emphasis on neoplastic alterations. J Urol, 2008. 180: 2463.

https://pubmed.ncbi.nlm.nih.gov/18930487/

803.Greiman, A.K., et al. Urethral diverticulum: A systematic review. Arab J Urol, 2019. 17: 49.

https://pubmed.ncbi.nlm.nih.gov/31258943/

804.Moran, P.A., et al. Urethral diverticula in pregnancy. Aust N Z J Obstet Gynaecol, 1998. 38: 102.

https://pubmed.ncbi.nlm.nih.gov/9521406/

805.Chang, Y.L., et al. Presentation of female urethral diverticulum is usually not typical. Urol Int, 2008. 80: 41.

https://pubmed.ncbi.nlm.nih.gov/18204232/

806.Ljungqvist, L., et al. Female urethral diverticulum: 26-year followup of a large series. J Urol, 2007. 177: 219.

https://pubmed.ncbi.nlm.nih.gov/17162049/

807.Enemchukwu, E., et al. Autologous Pubovaginal Sling for the Treatment of Concomitant Female Urethral Diverticula and Stress Urinary Incontinence. Urology, 2015. 85: 1300.

https://pubmed.ncbi.nlm.nih.gov/26099875/

808.Faerber, G.J. Urethral diverticulectomy and pubovaginal sling for simultaneous treatment of urethral diverticulum and intrinsic sphincter deficiency. Tech Urol, 1998. 4: 192.

https://pubmed.ncbi.nlm.nih.gov/9892000/

809.Romanzi, L.J., et al. Urethral diverticulum in women: diverse presentations resulting in diagnostic delay and mismanagement. J Urol, 2000. 164: 428.

https://pubmed.ncbi.nlm.nih.gov/10893602/

810.Swierzewski, S.J., 3rd, et al. Pubovaginal sling for treatment of female stress urinary incontinence complicated by urethral diverticulum. J Urol, 1993. 149: 1012.

https://pubmed.ncbi.nlm.nih.gov/8483202/

811.Dmochowski, R.R., et al. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol, 2010. 183: 1906.

https://pubmed.ncbi.nlm.nih.gov/20303102/

812.Nickles, S.W., et al. Simple vs complex urethral diverticulum: presentation and outcomes. Urology, 2014. 84: 1516.

https://pubmed.ncbi.nlm.nih.gov/25432847/

813.Bodner-Adler, B., et al. Surgical management of urethral diverticula in women: a systematic review. Int Urogynecol J, 2016. 27: 993.

https://pubmed.ncbi.nlm.nih.gov/26564222/

814.Ingber, M.S., et al. Surgically corrected urethral diverticula: long-term voiding dysfunction and reoperation rates. Urology, 2011. 77: 65.

https://pubmed.ncbi.nlm.nih.gov/20800882/

815.Rovner, E. Bladder and Female Urethral Diverticula. 2020.

https://www.researchgate.net/publication/301077196

816.Lee, U.J., et al. Rate of de novo stress urinary incontinence after urethal diverticulum repair. Urology, 2008. 71: 849.

https://pubmed.ncbi.nlm.nih.gov/18355904/

817.Laudano, M.A., et al. Pathologic Outcomes following Urethral Diverticulectomy in Women. Adv Urol, 2014. 2014: 861940.

https://pubmed.ncbi.nlm.nih.gov/24860605/

818.Tsivian, M., et al. Female urethral diverticulum: a pathological insight. Int Urogynecol J Pelvic Floor Dysfunct, 2009. 20: 957.

https://pubmed.ncbi.nlm.nih.gov/19582385/

819.Thomas, R.B., et al. Adenocarcinoma in a female urethral diverticulum. Aust N Z J Surg, 1991. 61: 869.

https://pubmed.ncbi.nlm.nih.gov/1750825/